Word,Tag
#10205208
Cost,O
comparison,O
of,O
predictive,O
genetic,O
testing,O
versus,O
conventional,O
clinical,O
screening,O
for,O
familial,O
adenomatous,O
polyposis,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,B-DNA_Mutation
Mutations,I-DNA_Mutation
of,O
the,O
APC,B-Gene_protein
gene,O
cause,O
familial,O
adenomatous,O
polyposis,O
(,O
FAP,O
),O
,,O
a,O
hereditary,O
colorectal,O
cancer,O
predisposition,O
syndrome,O
.,O
 , 


,O
#,O
#,O
AIMS,O

,O
To,O
conduct,O
a,O
cost,O
comparison,O
analysis,O
of,O
predictive,O
genetic,O
testing,O
versus,O
conventional,O
clinical,O
screening,O
for,O
individuals,O
at,O
risk,O
of,O
inheriting,O
FAP,O
,,O
using,O
the,O
perspective,O
of,O
a,O
third,O
party,O
payer,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
All,O
direct,O
health,O
care,O
costs,O
for,O
both,O
screening,O
strategies,O
were,O
measured,O
according,O
to,O
time,O
and,O
motion,O
,,O
and,O
the,O
expected,O
costs,O
evaluated,O
using,O
a,O
decision,O
analysis,O
model,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
The,O
baseline,O
analysis,O
predicted,O
that,O
screening,O
a,O
prototype,O
FAP,O
family,O
would,O
cost,O
$,O
4975/,O
pound3109,O
by,O
molecular,O
testing,O
and,O
$,O
8031/,O
pound5019,O
by,O
clinical,O
screening,O
strategy,O
,,O
when,O
family,O
members,O
were,O
monitored,O
with,O
the,O
same,O
frequency,O
of,O
clinical,O
surveillance,O
(,O
every,O
two,O
to,O
three,O
years,O
),O
.,O
 , 
Sensitivity,O
analyses,O
revealed,O
that,O
the,O
genetic,O
testing,O
approach,O
is,O
cost,O
saving,O
for,O
key,O
variables,O
including,O
the,O
kindred,O
size,O
,,O
the,O
age,O
of,O
screening,O
onset,O
,,O
and,O
the,O
cost,O
of,O
mutation,B-DNA_Mutation
identification,O
in,O
a,O
proband,O
.,O
 , 
However,O
,,O
if,O
the,O
APC,B-Gene_protein
mutation,B-DNA_Mutation
carriers,O
were,O
monitored,O
at,O
an,O
increased,O
(,O
annual,O
),O
frequency,O
,,O
the,O
cost,O
of,O
the,O
genetic,O
screening,O
strategy,O
increased,O
to,O
$,O
7483/,O
pound4677,O
and,O
was,O
especially,O
sensitive,O
to,O
variability,O
in,O
age,O
of,O
onset,O
of,O
screening,O
,,O
family,O
size,O
,,O
and,O
cost,O
of,O
genetic,O
testing,O
of,O
at,O
risk,O
relatives,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
 , 
In,O
FAP,O
kindreds,O
,,O
a,O
predictive,O
genetic,O
testing,O
strategy,O
costs,O
less,O
than,O
conventional,O
clinical,O
screening,O
,,O
provided,O
that,O
the,O
frequency,O
of,O
surveillance,O
is,O
identical,O
using,O
either,O
strategy,O
.,O
 , 
An,O
additional,O
significant,O
benefit,O
is,O
the,O
elimination,O
of,O
unnecessary,O
colonic,O
examinations,O
for,O
those,O
family,O
members,O
found,O
to,O
be,O
non,O
-,O
carriers,O
.,O
 , 

,O
 , 
#21063410
A,O
large,O
-,O
scale,O
meta,O
-,O
analysis,O
to,O
refine,O
colorectal,O
cancer,O
risk,O
estimates,O
associated,O
with,O
MUTYH,B-Gene_protein
variants,B-DNA_Mutation
.,I-DNA_Mutation
 , 



,O
#,O
#,O
BACKGROUND,O

,O
defective,O
DNA,O
repair,O
has,O
a,O
causal,O
role,O
in,O
hereditary,O
colorectal,O
cancer,O
(,O
CRC,O
),O
.,O
 , 
Defects,O
in,O
the,O
base,O
excision,O
repair,O
gene,O
MUTYH,B-Gene_protein
are,O
responsible,O
for,O
MUTYH,B-Gene_protein
-,I-Gene_protein
associated,O
polyposis,O
and,O
CRC,O
predisposition,O
as,O
an,O
autosomal,O
recessive,O
trait,O
.,O
 , 
Numerous,O
reports,O
have,O
suggested,O
MUTYH,B-Gene_protein
mono,B-DNA_Mutation
-,I-DNA_Mutation
allelic,I-DNA_Mutation
variants,I-DNA_Mutation
to,O
be,O
low,O
penetrance,O
risk,O
alleles,O
.,O
 , 
We,O
report,O
a,O
large,O
collaborative,O
meta,O
-,O
analysis,O
to,O
assess,O
and,O
refine,O
CRC,O
risk,O
estimates,O
associated,O
with,O
bi,O
-,O
allelic,O
and,O
mono,O
-,O
allelic,O
MUTYH,B-Gene_protein
variants,B-DNA_Mutation
and,O
investigate,O
age,O
and,O
sex,O
influence,O
on,O
risk,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,B-Gene_protein
MUTYH,I-Gene_protein
genotype,O
data,O
were,O
included,O
from,O
20,O
 ,O
565,O
cases,O
and,O
15,O
 ,O
524,O
controls,O
.,O
 , 
Three,O
logistic,O
regression,O
models,O
were,O
tested,O
:,O
a,O
crude,O
model,O
;,O
adjusted,O
for,O
age,O
and,O
sex,O
;,O
adjusted,O
for,O
age,O
,,O
sex,O
and,O
study,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
all,O
three,O
models,O
produced,O
very,O
similar,O
results,O
.,O
 , 
MUTYH,B-Gene_protein
bi,O
-,O
allelic,O
carriers,O
demonstrated,O
a,O
28,O
-,O
fold,O
increase,O
in,O
risk,O
(,O
95,O
%,O
confidence,O
interval,O
(,O
CI,O
):,O
6.95,O
-,O
115,O
),O
.,O
 , 
Significant,O
bi,O
-,O
allelic,O
effects,O
were,O
also,O
observed,O
for,O
G396D,B-Protein_Mutation
and,O
Y179C,B-Protein_Mutation
/,B-Protein_Mutation
G396D,I-Protein_Mutation
compound,O
heterozygotes,O
and,O
a,O
marginal,O
mono,O
-,O
allelic,O
effect,O
for,O
variant,B-Protein_Mutation
Y179C,B-Protein_Mutation
 , 
(,O
odds,O
ratio,O
(,O
OR)=1.34,O
;,O
95,O
%,O
CI,O
:,O
1.00,O
-,O
1.80,O
),O
.,O
 , 
A,O
pooled,O
meta,O
-,O
analysis,O
of,O
all,O
published,O
and,O
unpublished,O
datasets,O
submitted,O
showed,O
bi,O
-,O
allelic,O
effects,O
for,O
MUTYH,B-Gene_protein
,,I-Gene_protein
G396D,B-Protein_Mutation
and,O
Y179C,B-Protein_Mutation
(,O
OR=10.8,O
,,O
95,O
%,O
CI,O
:,O
5.02,O
-,O
23.2,O
;,O
OR=6.47,O
,,O
95,O
%,O
CI,O
:,O
2.33,O
-,O
18.0,O
;,O
OR=3.35,O
,,O
95,O
%,O
CI,O
:,O
1.14,O
-,O
9.89,O
),O
and,O
marginal,O
mono,O
-,O
allelic,O
effect,O
for,O
variants,B-DNA_Mutation
MUTYH,B-Gene_protein
(,O
OR=1.16,O
,,O
95,O
%,O
CI,O
:,O
1.00,O
-,O
1.34,O
),O
and,O
Y179C,B-Protein_Mutation
alone,O
(,O
OR=1.34,O
,,O
95,O
%,O
CI,O
:,O
1.01,O
-,O
1.77,O
),O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
overall,O
,,O
this,O
large,O
study,O
refines,O
estimates,O
of,O
disease,O
risk,O
associated,O
with,O
mono,O
-,O
allelic,O
and,O
bi,O
-,O
allelic,O
MUTYH,B-Gene_protein
carriers,O
.,O
 , 

,O
 , 
#9486818
Possible,O
role,O
of,O
telomerase,B-Gene_protein
activation,O
in,O
the,O
cancer,O
predisposition,O
of,O
patients,O
with,O
hereditary,O
nonpolyposis,O
colorectal,O
cancers,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
Hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
syndrome,O
(,O
HNPCC,O
syndrome,O
;,O
also,O
called,O
Lynch,O
syndrome,O
),O
 , 
is,O
one,O
of,O
the,O
most,O
common,O
cancer,O
predisposition,O
syndromes,O
.,O
 , 
Most,O
cases,O
of,O
cancer,O
associated,O
with,O
this,O
syndrome,O
are,O
due,O
to,O
the,O
inheritance,O
of,O
germline,O
mutations,B-DNA_Mutation
in,O
genes,O
that,O
encode,O
proteins,O
required,O
for,O
DNA,O
mismatch,O
repair,O
;,O
defects,O
in,O
these,O
proteins,O
allow,O
mutations,B-DNA_Mutation
to,O
accumulate,O
more,O
rapidly,O
in,O
the,O
DNA,O
and,O
influence,O
the,O
rate,O
of,O
cancer,O
development,O
.,O
 , 
Recent,O
studies,O
indicate,O
that,O
the,O
reactivation,O
of,O
the,O
activity,O
of,O
telomerase,B-Gene_protein
,,I-Gene_protein
an,O
enzyme,O
involved,O
in,O
the,O
synthesis,O
of,O
chromosomal,O
ends,O
,,O
in,O
somatic,O
cells,O
may,O
play,O
a,O
role,O
in,O
carcinogenesis,O
.,O
 , 
In,O
this,O
study,O
,,O
we,O
evaluated,O
the,O
expression,O
of,O
telomerase,B-Gene_protein
in,O
normal,O
and,O
cancerous,O
colorectal,O
tissue,O
specimens,O
from,O
HNPCC,O
and,O
non,O
-,O
HNPCC,O
patients,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
The,O
polymerase,O
chain,O
reaction,O
-,O
based,O
telomeric,O
repeat,O
amplification,O
protocol,O
was,O
used,O
to,O
assay,O
telomerase,B-Gene_protein
activity,O
in,O
colorectal,O
tissue,O
specimens,O
from,O
33,O
non,O
-,O
HNPCC,O
patients,O
(,O
23,O
normal,O
,,O
26,O
polyps,O
,,O
and,O
37,O
cancer,O
specimens,O
),O
and,O
from,O
24,O
HNPCC,O
patients,O
(,O
24,O
normal,O
,,O
0,O
polyps,O
,,O
and,O
28,O
cancer,O
specimens,O
),O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
Thirty,O
-,O
one,O
of,O
37,O
carcinoma,O
samples,O
from,O
18,O
non,O
-,O
HNPCC,O
patients,O
and,O
27,O
of,O
28,O
carcinoma,O
samples,O
from,O
24,O
HNPCC,O
patients,O
were,O
found,O
to,O
be,O
positive,O
for,O
telomerase,B-Gene_protein
activity,O
.,O
 , 
Whereas,O
only,O
one,O
of,O
23,O
normal,O
mucosa,O
samples,O
from,O
23,O
non,O
-,O
HNPCC,O
patients,O
was,O
found,O
to,O
have,O
(,O
weak,O
),O
telomerase,B-Gene_protein
activity,O
,,O
eight,O
of,O
24,O
normal,O
mucosa,O
samples,O
from,O
24,O
HNPCC,O
patients,O
were,O
positive,O
for,O
telomerase,B-Gene_protein
;,I-Gene_protein
the,O
difference,O
between,O
the,O
two,O
groups,O
was,O
statistically,O
significant,O
(,O
two,O
-,O
sided,O
P,O
=,O
.0226,O
),O
.,O
 , 


,O
#,O
#,O
IMPLICATION,O

,O
 , 
This,O
study,O
generates,O
the,O
hypothesis,O
that,O
genetic,O
defects,O
in,O
individuals,O
with,O
HNPCC,O
syndrome,O
facilitate,O
the,O
reactivation,O
of,O
telomerase,B-Gene_protein
activity,O
,,O
a,O
process,O
which,O
may,O
be,O
associated,O
with,O
their,O
predisposition,O
to,O
develop,O
cancer,O
.,O
 , 

,O
 , 
#7735559
Genetic,O
alterations,B-DNA_Mutation
of,O
microsatellites,B-locus
on,O
chromosome,B-locus
18,I-locus
in,O
human,O
breast,O
carcinoma,O
.,O
 , 


,O
Allelic,O
alterations,B-DNA_Mutation
of,O
chromosome,B-locus
18,I-locus
microsatellites,B-locus
were,O
determined,O
using,O
normal,O
and,O
tumor,O
DNA,O
pairs,O
from,O
29,O
patients,O
with,O
infiltrating,O
ductal,O
carcinoma,O
of,O
the,O
breast,O
.,O
 , 
Loss,B-DNA_Mutation
of,I-DNA_Mutation
heterozygosity,I-DNA_Mutation
was,O
detected,O
in,O
62,O
%,O
(,O
18,O
of,O
29,O
patients,O
),O
of,O
the,O
tumors,O
at,O
one,O
or,O
more,O
of,O
these,O
microsatellites,B-locus
.,I-locus
 , 
Eight,O
of,O
the,O
18,O
patients,O
exhibited,O
deletions,B-DNA_Mutation
in,O
the,O
region,O
at,O
18q21.1,B-locus
.,I-locus
 , 
This,O
chromosomal,O
band,O
is,O
known,O
to,O
contain,O
a,O
tumor,O
suppressor,O
gene,O
(,B-Gene_protein
DCC,I-Gene_protein
),I-Gene_protein
whose,O
expression,O
is,O
frequently,O
inactivated,O
in,O
several,O
types,O
of,O
cancer,O
.,O
 , 
Ten,O
other,O
patients,O
had,O
deletions,B-DNA_Mutation
in,O
regions,O
not,O
included,O
in,O
the,O
DCC,B-Gene_protein
locus,O
.,O
 , 
Five,O
of,O
these,O
patients,O
revealed,O
a,O
common,O
deletion,B-DNA_Mutation
at,O
the,O
D18S50,B-locus
locus,O
(,B-locus
18q23,I-locus
),I-locus
,,O
and,O
the,O
other,O
five,O
patients,O
had,O
deletions,B-DNA_Mutation
in,O
various,O
other,O
regions,O
of,O
the,O
chromosome,O
.,O
 , 
No,O
apparent,O
correlation,O
between,O
loss,B-DNA_Mutation
of,I-DNA_Mutation
heterozygosity,I-DNA_Mutation
of,O
chromosome,B-locus
18,I-locus
microsatellites,B-locus
and,O
the,O
clinical,O
stage,O
was,O
found,O
in,O
this,O
series,O
.,O
 , 
The,O
results,O
indicate,O
that,O
,,O
in,O
addition,O
to,O
the,O
DCC,B-Gene_protein
locus,O
,,O
the,O
18q23,B-locus
region,O
is,O
likely,O
to,O
contain,O
a,O
second,O
tumor,O
suppressor,O
gene,O
relevant,O
to,O
breast,O
carcinogenesis,O
.,O
 , 
Four,O
percent,O
of,O
all,O
microsatellites,B-locus
tested,O
in,O
these,O
patients,O
showed,O
allelic,B-DNA_Mutation
differences,I-DNA_Mutation
in,O
the,O
sizes,O
of,O
repeat,O
units,O
between,O
tumor,O
and,O
the,O
corresponding,O
constitutional,O
DNAs,O
.,O
 , 
The,O
pattern,O
of,O
allele,B-DNA_Mutation
instability,I-DNA_Mutation
observed,O
in,O
breast,O
carcinoma,O
differed,O
from,O
that,O
originally,O
reported,O
in,O
a,O
hereditary,O
type,O
of,O
colorectal,O
carcinoma,O
.,O
 , 
The,O
observation,O
suggests,O
that,O
this,O
phenomenon,O
is,O
not,O
a,O
mechanism,O
specific,O
to,O
neoplastic,O
processes,O
in,O
breast,O
carcinoma,O
.,O
 , 

,O
 , 
#16886602
Allelic,O
status,O
of,O
chromosomes,B-locus
17p,I-locus
,,I-locus
18q,I-locus
,,I-locus
22q,I-locus
[,I-locus
corrected,I-locus
],I-locus
3p,I-locus
and,O
their,O
clinical,O
usefulness,O
in,O
colorectal,O
cancer,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
To,O
determine,O
whether,O
the,O
allelic,O
status,O
of,O
chromosomes,O
is,O
clinically,O
useful,O
in,O
colorectal,O
cancer,O
,,O
the,O
allelic,B-DNA_Mutation
losses,I-DNA_Mutation
at,O
chromosomes,B-locus
17p,I-locus
,,I-locus
18q,I-locus
,,I-locus
22q,I-locus
and,I-locus
3p,I-locus
and,O
their,O
relationships,O
with,O
the,O
clinicopathological,O
features,O
in,O
colorectal,O
cancer,O
(,O
CRC,O
),O
patients,O
,,O
who,O
had,O
undergone,O
curative,O
surgery,O
without,O
adjuvant,O
chemotherapy,O
,,O
were,O
examined,O
.,O
 , 


,O
#,O
#,O
MATERIALS,O
AND,O
METHODS,O

,O
 , 
The,O
allelic,O
status,O
at,O
17p,B-locus
,,I-locus
18q,I-locus
,,I-locus
22q,I-locus
and,I-locus
3p,I-locus
was,O
analyzed,O
by,O
PCR,O
-,O
SSCP,O
(,O
polymerase,O
chain,O
reaction,O
single,O
-,O
strand,O
conformation,O
polymorphism,O
),O
in,O
139,O
CRC,O
from,O
patients,O
who,O
had,O
undergone,O
curative,O
surgery,O
between,O
October,O
1994,O
and,O
June,O
1996,O
.,O
 , 
The,O
relationships,O
between,O
these,O
allelic,B-DNA_Mutation
losses,I-DNA_Mutation
and,O
the,O
clinicopathological,O
features,O
were,O
investigated,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
The,O
lymph,O
node,O
status,O
was,O
significantly,O
associated,O
with,O
the,O
allelic,O
status,O
of,O
17p,B-locus
,,I-locus
18q,I-locus
and,I-locus
22q,I-locus
.,I-locus
 , 
The,O
tumor,O
site,O
and,O
tumor,O
differentiation,O
were,O
significantly,O
associated,O
with,O
the,O
allelic,O
status,O
of,O
18q,B-locus
.,I-locus
 , 
When,O
patients,O
with,O
more,O
than,O
two,O
allelic,B-DNA_Mutation
losses,I-DNA_Mutation
were,O
defined,O
as,O
the,O
high,O
allelic,B-DNA_Mutation
loss,I-DNA_Mutation
group,O
and,O
those,O
with,O
no,O
,,O
or,O
only,O
one,O
allelic,B-DNA_Mutation
loss,I-DNA_Mutation
were,O
defined,O
as,O
the,O
low,O
allelic,B-DNA_Mutation
loss,I-DNA_Mutation
group,O
,,O
it,O
was,O
found,O
that,O
the,O
lymph,O
node,O
involvement,O
was,O
significantly,O
higher,O
in,O
the,O
high,O
than,O
in,O
the,O
low,O
allelic,B-DNA_Mutation
loss,I-DNA_Mutation
group,O
.,O
 , 
Only,O
three,O
out,O
of,O
25,O
patients,O
in,O
the,O
low,O
allelic,B-DNA_Mutation
loss,I-DNA_Mutation
group,O
had,O
lymph,O
node,O
metastasis,O
,,O
and,O
15,O
patients,O
in,O
this,O
group,O
without,O
lymphatic,O
invasion,O
had,O
no,O
lymph,O
node,O
metastasis,O
.,O
 , 
There,O
was,O
no,O
relationship,O
between,O
the,O
allelic,O
status,O
and,O
survival,O
at,O
any,O
stage,O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
 , 
The,O
allelic,O
status,O
was,O
significantly,O
associated,O
with,O
lymph,O
node,O
metastasis,O
.,O
 , 
A,O
combination,O
of,O
allelic,O
status,O
and,O
lymphatic,O
invasion,O
assessment,O
can,O
predict,O
the,O
lymph,O
node,O
status,O
before,O
radical,O
surgery,O
.,O
 , 

,O
 , 
#22555244
Clinical,O
benefit,O
of,O
high,O
-,O
sensitivity,O
KRAS,B-Gene_protein
mutation,B-DNA_Mutation
testing,O
in,O
metastatic,O
colorectal,O
cancer,O
treated,O
with,O
anti,O
-,B-Gene_protein
EGFR,I-Gene_protein
antibody,O
therapy,O
.,O
 , 



,O
#,O
#,O
OBJECTIVE,O

,O
We,O
compared,O
high,O
-,O
sensitivity,O
KRAS,B-Gene_protein
mutation,B-DNA_Mutation
testing,O
with,O
direct,O
sequencing,O
for,O
predicting,O
the,O
efficacy,O
of,O
antiepidermal,B-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
receptor,I-Gene_protein
antibodies,O
in,O
patients,O
with,O
metastatic,O
colorectal,O
cancer,O
(,O
mCRC,O
),O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
We,O
analyzed,O
the,O
KRAS,B-Gene_protein
status,O
in,O
61,O
tumors,O
from,O
cetuximab,O
-,O
treated,O
mCRC,O
patients,O
by,O
both,O
direct,O
sequencing,O
and,O
a,O
high,O
-,O
sensitivity,O
method,O
:,O
2,O
-,O
step,O
PCR,O
restriction,O
fragmentation,O
length,O
polymorphism,O
(,O
RFLP,O
),O
.,O
 , 
Therapeutic,O
effects,O
in,O
each,O
mutational,B-DNA_Mutation
status,O
were,O
evaluated,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
The,O
incidences,O
of,O
KRAS,B-Gene_protein
mutations,B-DNA_Mutation
determined,O
by,O
direct,O
sequencing,O
and,O
2,O
-,O
step,O
PCR,O
RFLP,O
were,O
34.4,O
and,O
52.5,O
%,O
,,O
respectively,O
(,O
p,O
=,O
0.02,O
),O
.,O
 , 
Patients,O
were,O
categorized,O
into,O
3,O
groups,O
[,O
W,O
/,O
W,O
,,O
wild,O
-,O
type,O
by,O
both,O
methods,O
(,O
n,O
=,O
29,O
),O
;,O
W,O
/,O
M,O
,,O
wild,O
-,O
type,O
by,O
direct,O
sequencing,O
,,O
detected,O
mutation,B-DNA_Mutation
by,O
2,O
-,O
step,O
PCR,O
RFLP,O
(,O
n,O
=,O
11,O
),O
;,O
M,O
/,O
M,O
,,O
mutant,B-DNA_Mutation
-,I-DNA_Mutation
type,O
by,O
both,O
methods,O
(,O
n,O
=,O
21,O
),O
],O
.,O
 , 
The,O
response,O
rate,O
for,O
cetuximab,O
in,O
the,O
W,O
/,O
M,O
group,O
(,O
0,O
%,O
),O
was,O
the,O
same,O
as,O
that,O
in,O
the,O
M,O
/,O
M,O
group,O
,,O
and,O
was,O
significantly,O
lower,O
than,O
in,O
the,O
W,O
/,O
W,O
group,O
(,O
41.4,O
%,O
),O
(,O
p,O
<,O
0.001,O
),O
.,O
 , 
Progression,O
-,O
free,O
survival,O
in,O
the,O
W,O
/,O
M,O
group,O
(,O
11.0,O
weeks,O
),O
was,O
similar,O
to,O
that,O
in,O
the,O
M,O
/,O
M,O
group,O
(,O
8.0,O
weeks,O
),O
,,O
and,O
was,O
significantly,O
shorter,O
than,O
in,O
the,O
W,O
/,O
W,O
group,O
(,O
18.0,O
weeks,O
),O
 , 
(,O
p,O
<,O
0.002,O
),O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
High,O
-,O
sensitivity,O
KRAS,B-Gene_protein
mutation,B-DNA_Mutation
testing,O
is,O
useful,O
for,O
selecting,O
true,O
responders,O
to,O
cetuximab,O
.,O
 , 

,O
 , 
#17949294
Similar,O
colorectal,O
cancer,O
risk,O
in,O
patients,O
with,O
monoallelic,B-DNA_Mutation
and,I-DNA_Mutation
biallelic,I-DNA_Mutation
mutations,I-DNA_Mutation
in,O
the,O
MYH,B-Gene_protein
gene,O
identified,O
in,O
a,O
population,O
with,O
adenomatous,O
polyposis,O
.,O
 , 


,O
A,O
large,O
proportion,O
of,O
non,O
-,O
FAP,O
non,O
-,O
HNPCC,O
patients,O
with,O
multiple,O
colorectal,O
adenomas,O
have,O
been,O
reported,O
to,O
carry,O
germline,O
mutations,B-DNA_Mutation
on,O
the,O
MYH,B-Gene_protein
gene,O
.,O
 , 
Although,O
the,O
number,O
of,O
adenomas,O
appears,O
to,O
be,O
dependent,O
on,O
the,O
number,O
of,O
mutated,B-DNA_Mutation
MYH,B-Gene_protein
alleles,O
present,O
in,O
a,O
patient,O
,,O
little,O
is,O
known,O
on,O
the,O
relation,O
of,O
this,O
number,O
with,O
cancer,O
risk,O
.,O
 , 
Four,O
hundred,O
fifty,O
-,O
three,O
APC,B-Gene_protein
-,I-Gene_protein
negative,O
patients,O
with,O
more,O
than,O
five,O
colorectal,O
adenomas,O
were,O
screened,O
for,O
mutations,B-DNA_Mutation
on,O
the,O
entire,O
coding,O
sequence,O
of,O
the,O
MYH,B-Gene_protein
gene,O
.,O
 , 
Pathogenic,O
mutations,B-DNA_Mutation
were,O
initially,O
found,O
in,O
74,O
patients,O
without,O
extradigestive,O
tumors,O
(,O
22.5,O
%,O
),O
and,O
subsequently,O
in,O
75,O
at,O
-,O
risk,O
relatives,O
.,O
 , 
Polyposis,O
was,O
more,O
severe,O
in,O
cases,O
with,O
biallelic,B-DNA_Mutation
mutations,I-DNA_Mutation
.,I-DNA_Mutation
 , 
However,O
,,O
mutation,B-DNA_Mutation
copy,O
number,O
was,O
correlated,O
neither,O
with,O
the,O
age,O
at,O
diagnosis,O
of,O
adenomas,O
or,O
adenocarcinomas,O
,,O
nor,O
with,O
the,O
presence,O
of,O
a,O
family,O
history,O
of,O
colorectal,O
tumors,O
.,O
 , 
Heterozygous,O
and,O
homozygous,O
MYH,B-Gene_protein
mutation,B-DNA_Mutation
carriers,O
were,O
both,O
at,O
high,O
risk,O
for,O
synchronous,O
cancers,O
(,O
24,O
%,O
in,O
colorectum,O
and,O
16,O
%,O
in,O
the,O
upper,O
gastrointestinal,O
tract,O
),O
,,O
but,O
did,O
not,O
demonstrate,O
an,O
increased,O
risk,O
for,O
extradigestive,O
tumors,O
.,O
 , 
MYH,B-Gene_protein
-,I-Gene_protein
associated,O
polyposis,O
is,O
a,O
frequent,O
inherited,O
colorectal,O
cancer,O
predisposition,O
with,O
a,O
strong,O
dominance,O
component,O
.,O
 , 
From,O
age,O
25,O
-,O
30,O
,,O
MYH,B-Gene_protein
mutation,B-DNA_Mutation
carriers,O
should,O
be,O
proposed,O
an,O
early,O
screening,O
program,O
,,O
which,O
includes,O
endoscopies,O
of,O
the,O
upper,O
digestive,O
tract,O
and,O
the,O
colorectum,O
every,O
2,O
years,O
.,O
 , 

,O
 , 
#12145419
Ulcerative,O
colitis,O
and,O
colon,O
cancer,O
:,O
strategies,O
for,O
cancer,O
prevention,O
.,O
 , 


,O
The,O
risk,O
of,O
development,O
of,O
colon,O
cancer,O
in,O
patients,O
with,O
ulcerative,O
colitis,O
is,O
an,O
emotive,O
issue,O
with,O
patients,O
and,O
a,O
potential,O
medico,O
-,O
legal,O
problem,O
for,O
physicians,O
caring,O
for,O
such,O
patients,O
.,O
 , 
The,O
exact,O
magnitude,O
of,O
the,O
risk,O
is,O
not,O
clearly,O
defined,O
.,O
 , 
Current,O
surveillance,O
programmes,O
use,O
dysplasia,O
as,O
a,O
marker,O
for,O
the,O
risk,O
of,O
invasive,O
carcinoma,O
development,O
,,O
but,O
this,O
strategy,O
has,O
inherent,O
limitations,O
.,O
 , 
A,O
number,O
of,O
new,O
molecular,O
markers,O
have,O
been,O
investigated,O
but,O
none,O
are,O
currently,O
considered,O
robust,O
enough,O
for,O
routine,O
clinical,O
use,O
.,O
 , 
Recommendations,O
for,O
patient,O
selection,O
and,O
interval,O
for,O
colonoscopic,O
surveillance,O
are,O
currently,O
pragmatic,O
,,O
and,O
not,O
entirely,O
evidence,O
-,O
based,O
.,O
 , 
Nevertheless,O
,,O
optimal,O
medical,O
management,O
and,O
adherence,O
to,O
a,O
surveillance,O
programme,O
geared,O
to,O
detect,O
dysplasia,O
might,O
still,O
be,O
the,O
best,O
risk,O
reduction,O
strategy,O
.,O
 , 

,O
 , 
#18256278
A,O
mutant,B-DNA_Mutation
allele,O
of,O
MRE11,B-Gene_protein
found,O
in,O
mismatch,O
repair,O
-,O
deficient,O
tumor,O
cells,O
suppresses,O
the,O
cellular,O
response,O
to,O
DNA,O
replication,O
fork,O
stress,O
in,O
a,O
dominant,O
negative,O
manner,O
.,O
 , 


,O
The,O
interaction,O
of,O
ataxia,B-Gene_protein
-,I-Gene_protein
telangiectasia,I-Gene_protein
mutated,I-Gene_protein
(,B-Gene_protein
ATM,I-Gene_protein
),I-Gene_protein
and,O
the,O
Mre11,B-Gene_protein
/,B-Gene_protein
Rad50,I-Gene_protein
/,B-Gene_protein
Nbs1,I-Gene_protein
(,O
MRN,O
),O
complex,O
is,O
critical,O
for,O
the,O
response,O
of,O
cells,O
to,O
DNA,O
double,O
-,O
strand,O
breaks,O
;,O
however,O
,,O
little,O
is,O
known,O
of,O
the,O
role,O
of,O
these,O
proteins,O
in,O
response,O
to,O
DNA,O
replication,O
stress,O
.,O
 , 
Here,O
,,O
we,O
report,O
a,O
mutant,B-DNA_Mutation
allele,O
of,O
MRE11,B-Gene_protein
found,O
in,O
a,O
colon,O
cancer,O
cell,O
line,O
that,O
sensitizes,O
cells,O
to,O
agents,O
causing,O
replication,O
fork,O
stress,O
.,O
 , 
The,O
mutant,B-DNA_Mutation
Mre11,B-Gene_protein
weakly,O
interacts,O
with,O
Rad50,B-Gene_protein
relative,O
to,O
wild,O
type,O
and,O
shows,O
little,O
affinity,O
for,O
Nbs1,B-Gene_protein
.,I-Gene_protein
 , 
The,O
mutant,B-DNA_Mutation
protein,O
lacks,O
3'-5,O
',O
exonuclease,O
activity,O
as,O
a,O
result,O
of,O
loss,O
of,O
part,O
of,O
the,O
conserved,O
nuclease,O
domain,O
;,O
however,O
,,O
it,O
retains,O
binding,O
affinity,O
for,O
single,O
-,O
stranded,O
DNA,O
(,O
ssDNA,O
),O
,,O
double,O
-,O
stranded,O
DNA,O
with,O
a,O
3,O
',O
single,O
-,O
strand,O
overhang,O
,,O
and,O
fork,O
-,O
like,O
structures,O
containing,O
ssDNA,O
regions,O
.,O
 , 
In,O
cells,O
,,O
the,O
mutant,B-DNA_Mutation
protein,O
shows,O
a,O
time-,O
and,O
dose,O
-,O
dependent,O
accumulation,O
in,O
chromatin,O
after,O
thymidine,O
treatment,O
that,O
corresponds,O
with,O
increased,O
recruitment,O
and,O
hyperphosphorylation,O
of,O
replication,B-Gene_protein
protein,I-Gene_protein
A.,I-Gene_protein
ATM,B-Gene_protein
autophosphorylation,O
,,O
Mre11,B-Gene_protein
foci,O
,,O
and,O
thymidine,O
-,O
induced,O
homologous,O
recombination,O
are,O
suppressed,O
in,O
cells,O
expressing,O
the,O
mutant,B-DNA_Mutation
allele,O
.,O
 , 
Together,O
,,O
our,O
results,O
suggest,O
that,O
the,O
mutant,B-DNA_Mutation
Mre11,B-Gene_protein
suppresses,O
the,O
cellular,O
response,O
to,O
replication,O
stress,O
by,O
binding,O
to,O
ssDNA,O
regions,O
at,O
disrupted,O
forks,O
and,O
impeding,O
replication,O
restart,O
in,O
a,O
dominant,O
negative,O
manner,O
.,O
 , 

,O
 , 
#19471308
A,O
genome,O
-,O
wide,O
scan,O
of,O
10,O
000,O
gene,O
-,O
centric,O
variants,B-DNA_Mutation
and,O
colorectal,O
cancer,O
risk,O
.,O
 , 


,O
Genome,O
scans,O
based,O
on,O
gene,O
-,O
centric,O
single,B-DNA_Mutation
nucleotide,I-DNA_Mutation
polymorphisms,I-DNA_Mutation
(,B-DNA_Mutation
SNPs,I-DNA_Mutation
),I-DNA_Mutation
have,O
been,O
proposed,O
as,O
an,O
efficient,O
approach,O
to,O
identify,O
disease,O
-,O
causing,O
variants,B-DNA_Mutation
that,O
is,O
complementary,O
to,O
scans,O
based,O
on,O
tagging,O
SNPs,B-DNA_Mutation
.,I-DNA_Mutation
 , 
Adopting,O
this,O
approach,O
to,O
identify,O
low,O
-,O
penetrance,O
susceptibility,O
alleles,O
for,O
colorectal,O
cancer,O
(,O
CRC,O
),O
we,O
analysed,O
genotype,O
data,O
from,O
9109,O
gene,O
-,O
centric,O
SNPs,B-DNA_Mutation
,,I-DNA_Mutation
7014,O
of,O
which,O
were,O
non,O
-,O
synonymous,O
(,O
nsSNPs,B-DNA_Mutation
),I-DNA_Mutation
,,O
in,O
2873,O
cases,O
and,O
2871,O
controls,O
using,O
Illumina,O
iselect,O
arrays,O
.,O
 , 
Overall,O
the,O
distribution,O
of,O
associations,O
was,O
not,O
significantly,O
different,O
from,O
the,O
null,O
.,O
 , 
No,O
SNP,B-DNA_Mutation
achieved,O
globally,O
significant,O
association,O
after,O
correction,O
for,O
multiple,O
testing,O
(,O
lowest,O
P,O
value,O
1.7,O
x,O
10(-4,O
),O
,,O
rs727299,B-dbSNP
),I-dbSNP
.,O
 , 
We,O
then,O
analysed,O
the,O
dataset,O
incorporating,O
information,O
on,O
the,O
functional,O
consequences,O
of,O
nsSNPs,B-DNA_Mutation
.,I-DNA_Mutation
 , 
We,O
used,O
results,O
from,O
the,O
in,O
silico,O
algorithm,O
PolyPhen,O
as,O
prior,O
information,O
to,O
weight,O
the,O
association,O
statistics,O
,,O
with,O
weights,O
estimated,O
from,O
the,O
observed,O
test,O
statistics,O
within,O
predefined,O
groups,O
of,O
SNPs,B-DNA_Mutation
.,I-DNA_Mutation
 , 
Incorporating,O
this,O
information,O
did,O
not,O
,,O
however,O
,,O
yield,O
any,O
further,O
evidence,O
of,O
a,O
specific,O
association,O
(,O
lowest,O
P,O
value,O
2.2,O
x,O
10(-4,O
),O
,,O
rs1133950,B-dbSNP
),I-dbSNP
.,O
 , 
There,O
was,O
a,O
strong,O
relationship,O
between,O
effect,O
size,O
and,O
SNPs,B-DNA_Mutation
predicted,O
to,O
be,O
damaging,O
(,O
P=1.63,O
x,O
10(-5,O
),O
),O
,,O
however,O
,,O
these,O
variants,B-DNA_Mutation
which,O
are,O
most,O
likely,O
to,O
impact,O
on,O
risk,O
are,O
rare,O
(,O
MAF<5,O
%,O
),O
.,O
 , 
Hence,O
although,O
the,O
rationale,O
for,O
searching,O
for,O
low,O
-,O
penetrance,O
cancer,O
susceptibly,O
alleles,O
by,O
conducting,O
genome,O
-,O
wide,O
scans,O
of,O
coding,O
changes,O
is,O
strong,O
,,O
in,O
practice,O
it,O
is,O
likely,O
that,O
natural,O
selection,O
has,O
rendered,O
such,O
alleles,O
to,O
be,O
too,O
rare,O
to,O
be,O
detected,O
by,O
association,O
studies,O
of,O
the,O
size,O
employed,O
.,O
 , 

,O
 , 
#9815896
Antibody,O
to,O
ras,O
proteins,O
in,O
patients,O
with,O
colon,O
cancer,O
.,O
 , 


,O
The,O
current,O
study,O
examined,O
sera,O
from,O
160,O
colon,O
cancer,O
patients,O
and,O
60,O
normal,O
individuals,O
to,O
determine,O
whether,O
antibody,O
to,O
mutated,B-Protein_Mutation
p21,B-Gene_protein
ras,I-Gene_protein
protein,O
was,O
present,O
.,O
 , 
Studies,O
focused,O
on,O
the,O
aspartic,B-Protein_Mutation
acid,I-Protein_Mutation
substitution,I-Protein_Mutation
at,O
amino,B-locus
acid,I-locus
position,I-locus
12,I-locus
(,O
denoted,O
D12,B-Protein_Mutation
),I-Protein_Mutation
,,O
one,O
of,O
the,O
most,O
common,O
mutations,B-Protein_Mutation
in,O
colon,O
adenocarcinoma,O
.,O
 , 
IgA,B-Gene_protein
antibodies,O
directed,O
against,O
mutated,B-Protein_Mutation
p21,B-Gene_protein
ras,I-Gene_protein
-,I-Gene_protein
D12,I-Protein_Mutation
protein,O
were,O
detected,O
in,O
51,O
(,O
32,O
%,O
),O
of,O
160,O
colon,O
cancer,O
patients,O
,,O
but,O
only,O
in,O
1,O
(,O
2.5,O
%,O
),O
of,O
40,O
normal,O
individuals,O
.,O
 , 
The,O
greater,O
incidence,O
of,O
antibody,O
in,O
cancer,O
patients,O
provides,O
presumptive,O
evidence,O
that,O
immunization,O
to,O
the,O
ras,O
proteins,O
occurred,O
as,O
a,O
result,O
of,O
the,O
malignancy,O
.,O
 , 
Examination,O
of,O
sera,O
for,O
antibody,O
reactivity,O
to,O
wild,O
-,O
type,O
p21,B-Gene_protein
ras,I-Gene_protein
protein,O
(,O
denoted,O
p21,B-Gene_protein
ras,I-Gene_protein
-,I-Gene_protein
G12,O
),O
as,O
well,O
as,O
p21,B-Gene_protein
ras,I-Gene_protein
proteins,O
bearing,O
the,O
D12,B-Protein_Mutation
,,I-Protein_Mutation
V12,B-Protein_Mutation
,,I-Protein_Mutation
S12,B-Protein_Mutation
,,I-Protein_Mutation
or,O
L61,B-Protein_Mutation
mutations,B-Protein_Mutation
showed,O
that,O
antibody,O
detected,O
was,O
largely,O
to,O
normal,O
segments,O
of,O
the,O
p21,B-Gene_protein
ras,I-Gene_protein
protein,O
.,O
 , 
Epitope,O
mapping,O
,,O
using,O
peptide,O
neutralization,O
assays,O
with,O
mutated,B-Protein_Mutation
or,O
normal,O
ras,O
peptides,O
as,O
competitors,O
,,O
demonstrated,O
that,O
in,O
10,O
(,O
67,O
%,O
),O
of,O
15,O
sera,O
examined,O
the,O
antibody,O
reactivity,O
to,O
p21,B-Gene_protein
ras,I-Gene_protein
-,I-Gene_protein
G12,O
protein,O
was,O
neutralized,O
by,O
peptides,O
near,O
the,O
carboxyl,O
terminus,O
of,O
p21,B-Gene_protein
ras,I-Gene_protein
protein,O
,,O
but,O
not,O
by,O
peptides,O
spanning,O
the,O
specific,O
point,O
mutation,B-Protein_Mutation
region,O
.,O
 , 
Antibody,O
reactivities,O
correlated,O
with,O
peripheral,O
blood,O
lymphocyte,O
count,O
,,O
but,O
did,O
not,O
correlate,O
with,O
patient,O
age,O
,,O
sex,O
,,O
histology,O
,,O
stage,O
,,O
tumor,O
locus,O
,,O
lymph,O
node,O
metastasis,O
,,O
or,O
serum,O
carcinoembryonic,O
antigen,O
.,O

,O
 , 
#16030091
The,O
role,O
of,O
cytokine,O
gene,O
polymorphisms,B-DNA_Mutation
in,O
colorectal,O
cancer,O
and,O
their,O
interaction,O
with,O
aspirin,O
use,O
in,O
the,O
northeast,O
of,O
Scotland,O
.,O
 , 


,O
The,O
reduced,O
risk,O
of,O
colorectal,O
cancer,O
associated,O
with,O
cyclooxygenase,O
enzyme,O
inhibitors,O
,,O
such,O
as,O
aspirin,O
and,O
other,O
nonsteroidal,O
anti,O
-,O
inflammatory,O
drugs,O
,,O
strongly,O
suggests,O
that,O
chronic,O
inflammation,O
is,O
a,O
key,O
mediator,O
in,O
the,O
development,O
of,O
colorectal,O
cancer,O
.,O
 , 
This,O
complements,O
recent,O
molecular,O
evidence,O
demonstrating,O
an,O
association,O
between,O
a,O
number,O
of,O
proinflammatory,O
genetic,O
polymorphisms,B-DNA_Mutation
and,O
risk,O
of,O
colorectal,O
cancer,O
.,O
 , 
We,O
assessed,O
polymorphisms,B-DNA_Mutation
in,O
the,O
IL-1,B-Gene_protein
,,I-Gene_protein
IL-10,B-Gene_protein
,,I-Gene_protein
TNF,B-Gene_protein
-,I-Gene_protein
A,I-Gene_protein
,,I-Gene_protein
and,O
TGF,B-Gene_protein
-,I-Gene_protein
B,I-Gene_protein
genes,O
in,O
a,O
population,O
-,O
based,O
case,O
-,O
control,O
study,O
of,O
colorectal,O
cancer,O
cases,O
(,O
n,O
=,O
264,O
),O
and,O
frequency,O
-,O
matched,O
controls,O
(,O
n,O
=,O
408,O
),O
in,O
the,O
Northeast,O
of,O
Scotland,O
and,O
analyzed,O
their,O
interaction,O
with,O
regular,O
aspirin,O
use,O
.,O
 , 
There,O
was,O
no,O
evidence,O
of,O
a,O
relation,O
between,O
any,O
of,O
the,O
individual,O
polymorphisms,B-DNA_Mutation
,,I-DNA_Mutation
or,O
pairs,O
of,O
polymorphisms,B-DNA_Mutation
,,I-DNA_Mutation
and,O
risk,O
of,O
colorectal,O
cancer,O
.,O
 , 
There,O
was,O
a,O
significant,O
interaction,O
between,O
the,O
IL-10,B-Gene_protein
-,I-Gene_protein
592,I-locus
C,O
/,O
A,O
polymorphism,B-DNA_Mutation
and,O
aspirin,O
use,O
(,O
Pinteraction,O
=,O
0.03,O
),O
.,O
 , 
Carriers,O
of,O
the,O
variant,B-DNA_Mutation
IL-10,B-Gene_protein
-,I-Gene_protein
592,I-locus
(,O
A,O
),O
allele,O
,,O
who,O
produce,O
less,O
of,O
the,O
anti,O
-,O
inflammatory,O
cytokine,O
interleukin-10,B-Gene_protein
,,I-Gene_protein
had,O
a,O
statistically,O
significant,O
50,O
%,O
reduced,O
risk,O
of,O
colorectal,O
cancer,O
when,O
taking,O
regular,O
aspirin,O
(,O
odds,O
ratio,O
,,O
0.5,O
;,O
95,O
%,O
confidence,O
interval,O
,,O
0.25,O
-,O
0.97,O
),O
,,O
whereas,O
risk,O
was,O
not,O
reduced,O
in,O
carriers,O
of,O
the,O
A,O
allele,O
who,O
did,O
not,O
use,O
aspirin,O
,,O
or,O
among,O
aspirin,O
users,O
with,O
the,O
CC,O
genotype,O
.,O
 , 
It,O
is,O
possible,O
that,O
carriers,O
of,O
the,O
mutant,B-DNA_Mutation
IL-10,B-locus
-,I-locus
592,I-locus
allele,O
are,O
more,O
likely,O
to,O
derive,O
anti,O
-,O
inflammatory,O
and,O
chemopreventive,O
benefits,O
from,O
aspirin,O
in,O
the,O
presence,O
of,O
a,O
lower,O
production,O
of,O
their,O
own,O
endogenous,O
anti,O
-,O
inflammatory,O
interleukin-10,B-Gene_protein
.,I-Gene_protein
 , 
These,O
results,O
suggest,O
that,O
host,O
genetics,O
may,O
play,O
a,O
role,O
in,O
predicting,O
response,O
to,O
chemopreventive,O
strategies,O
.,O
 , 
Confirmation,O
of,O
these,O
findings,O
in,O
other,O
populations,O
is,O
required,O
.,O
 , 

,O
 , 
#12475549
Hereditary,O
risk,O
of,O
women,O
's,O
cancers,O
.,O
 , 


,O
The,O
characterization,O
of,O
specific,O
genes,O
responsible,O
for,O
the,O
hereditary,O
risk,O
of,O
common,O
cancers,O
has,O
enabled,O
the,O
development,O
of,O
clinical,O
tests,O
designed,O
to,O
identify,O
at,O
-,O
risk,O
individuals,O
and,O
to,O
significantly,O
improve,O
the,O
clinical,O
outcome,O
of,O
such,O
individuals,O
.,O
 , 
Two,O
of,O
the,O
most,O
important,O
syndromes,O
associated,O
with,O
a,O
hereditary,O
risk,O
of,O
cancer,O
in,O
women,O
are,O
hereditary,O
breast,O
and,O
ovarian,O
cancer,O
,,O
resulting,O
from,O
the,O
BRCA1,B-Gene_protein
and,O
BRCA2,B-Gene_protein
genes,O
,,O
and,O
hereditary,O
non,O
-,O
polyposis,O
colorectal,O
cancer,O
,,O
caused,O
primarily,O
by,O
the,O
MLH1,B-Gene_protein
and,O
MSH2,B-Gene_protein
genes,O
.,O
 , 
As,O
testing,O
for,O
the,O
hereditary,O
risk,O
of,O
breast,O
,,O
ovarian,O
,,O
endometrial,O
and,O
colorectal,O
cancer,O
enters,O
the,O
clinical,O
mainstream,O
,,O
physicians,O
responsible,O
for,O
the,O
health,O
care,O
of,O
women,O
are,O
increasingly,O
required,O
to,O
assess,O
and,O
provide,O
guidance,O
to,O
healthy,O
patients,O
with,O
a,O
strong,O
family,O
history,O
,,O
cancer,O
survivors,O
who,O
may,O
be,O
at,O
risk,O
of,O
a,O
second,O
cancer,O
and,O
women,O
who,O
discover,O
that,O
a,O
family,O
member,O
carries,O
a,O
specific,O
mutation,B-DNA_Mutation
identified,O
through,O
genetic,O
testing,O
.,O
 , 
Obstetricians,O
and,O
gynaecologists,O
must,O
therefore,O
become,O
familiar,O
with,O
the,O
principles,O
of,O
assessing,O
the,O
family,O
history,O
for,O
specific,O
hereditary,O
cancer,O
syndromes,O
,,O
with,O
the,O
appropriate,O
use,O
of,O
tests,O
to,O
confirm,O
such,O
syndromes,O
and,O
with,O
the,O
management,O
options,O
for,O
women,O
who,O
have,O
inherited,O
a,O
greatly,O
increased,O
risk,O
of,O
cancer,O
.,O
 , 

,O
 , 
#12500293
Numerical,B-DNA_Mutation
abnormalities,I-DNA_Mutation
of,O
chromosomes,B-locus
17,I-locus
and,I-locus
18,I-locus
in,O
sporadic,O
colorectal,O
cancer,O
:,O
Incidence,O
and,O
correlation,O
with,O
clinical,O
and,O
biological,O
findings,O
and,O
the,O
prognosis,O
of,O
the,O
disease,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
 , 
In,O
recent,O
years,O
important,O
information,O
has,O
accumulated,O
on,O
the,O
genetic,B-DNA_Mutation
alterations,I-DNA_Mutation
present,O
in,O
colorectal,O
tumors,O
.,O
 , 
However,O
,,O
thus,O
far,O
few,O
studies,O
have,O
analyzed,O
the,O
impact,O
of,O
numerical,B-DNA_Mutation
abnormalities,I-DNA_Mutation
of,O
chromosomes,B-locus
17,I-locus
and,I-locus
18,I-locus
,,I-locus
which,O
carry,O
the,O
p53,B-Gene_protein
and,O
DCC,B-Gene_protein
plus,O
SHAD4,B-Gene_protein
/,I-Gene_protein
DPC4,I-Gene_protein
genes,O
involved,O
in,O
colorectal,O
cancer,O
,,O
on,O
the,O
clinical,O
and,O
biological,O
behaviors,O
of,O
the,O
disease,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
 , 
With,O
the,O
use,O
of,O
interphase,O
fluorescence,O
in,O
situ,O
hybridization,O
(,O
FISH,O
),O
,,O
we,O
analyzed,O
the,O
incidence,O
of,O
numerical,B-DNA_Mutation
abnormalities,I-DNA_Mutation
of,O
chromosomes,B-locus
17,I-locus
and,I-locus
18,I-locus
in,O
a,O
series,O
of,O
malignant,O
colorectal,O
tumors,O
and,O
explored,O
its,O
potential,O
association,O
with,O
clinicobiological,O
behavior,O
and,O
the,O
prognosis,O
of,O
the,O
disease,O
.,O
 , 
For,O
this,O
purpose,O
,,O
94,O
consecutive,O
patients,O
newly,O
diagnosed,O
with,O
colorectal,O
cancer,O
were,O
analyzed,O
.,O
 , 
In,O
all,O
cases,O
,,O
FISH,O
analyses,O
of,O
the,O
number,O
of,O
copies,O
and,O
nuclei,O
of,O
chromosomes,B-locus
17,I-locus
and,I-locus
18,I-locus
were,O
performed,O
in,O
interphase,O
nuclei,O
with,O
the,O
use,O
of,O
double,O
stainings,O
.,O
 , 
For,O
all,O
patients,O
,,O
information,O
on,O
age,O
,,O
sex,O
,,O
tumor,O
size,O
,,O
Dukes,O
',O
stage,O
,,O
tumor,O
localization,O
,,O
DNA,O
ploidy,O
status,O
,,O
and,O
the,O
proportion,O
of,O
S,O
-,O
phase,O
tumor,O
cells,O
was,O
recorded,O
.,O
 , 
Median,O
follow,O
-,O
up,O
was,O
38,O
months,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,B-DNA_Mutation
Numerical,I-DNA_Mutation
abnormalities,I-DNA_Mutation
of,O
chromosomes,B-locus
17,I-locus
and,I-locus
18,I-locus
were,O
present,O
in,O
most,O
patients,O
with,O
colorectal,O
cancer,O
(,O
57,O
%,O
and,O
52,O
%,O
,,O
respectively,O
),O
.,O
 , 
Gains,B-Mutation
of,O
chromosome,B-locus
17,I-locus
and,O
monosomy,B-DNA_Mutation
18,I-DNA_Mutation
were,O
found,O
in,O
51,O
%,O
and,O
29,O
%,O
of,O
cases,O
,,O
respectively,O
,,O
and,O
they,O
were,O
the,O
most,O
frequent,O
individual,O
abnormalities,B-DNA_Mutation
for,O
each,O
chromosome,O
.,O
 , 
The,O
simultaneous,O
analysis,O
of,O
the,O
number,O
of,O
copies,O
of,O
both,O
chromosomes,O
in,O
the,O
same,O
cell,O
showed,O
that,O
,,O
in,O
most,O
cases,O
displaying,O
numerical,B-DNA_Mutation
abnormalities,I-DNA_Mutation
for,O
these,O
chromosomes,O
,,O
two,O
or,O
more,O
different,O
tumor,O
cell,O
clones,O
were,O
present,O
.,O
 , 
From,O
a,O
clinical,O
point,O
of,O
view,O
,,O
numerical,B-DNA_Mutation
abnormalities,I-DNA_Mutation
of,O
chromosome,B-locus
17,I-locus
,,I-locus
especially,O
monosomy,B-DNA_Mutation
17,I-DNA_Mutation
,,I-DNA_Mutation
were,O
associated,O
with,O
a,O
significantly,O
higher,O
incidence,O
of,O
rectal,O
tumors,O
(,O
P,O
=,O
0.001,O
),O
and,O
Dukes,O
',O
stage,O
D,O
(,O
P,O
=,O
0.02,O
),O
and,O
a,O
lower,O
median,O
of,O
disease,O
-,O
free,O
survival,O
among,O
patients,O
who,O
underwent,O
curative,O
surgery,O
(,O
P,O
=,O
0.05,O
),O
,,O
as,O
compared,O
with,O
diploid,O
cases,O
.,O
 , 
In,O
addition,O
,,O
cases,O
with,O
an,O
altered,B-DNA_Mutation
number,I-DNA_Mutation
of,I-DNA_Mutation
copies,I-DNA_Mutation
of,O
chromosome,B-locus
17,I-locus
showed,O
a,O
higher,O
incidence,O
of,O
DNA,O
aneuploidy,B-DNA_Mutation
(,O
P,O
=,O
0.0001,O
),O
and,O
a,O
greater,O
proportion,O
of,O
S,O
-,O
phase,O
cells,O
(,O
P,O
=,O
0.001,O
),O
by,O
flow,O
cytometry,O
.,O
 , 
In,O
contrast,O
,,O
no,O
clear,O
association,O
was,O
found,O
between,O
the,O
presence,O
of,O
numerical,B-DNA_Mutation
abnormalities,I-DNA_Mutation
of,O
chromosome,B-locus
18,I-locus
and,O
clinicobiological,O
disease,O
characteristics,O
,,O
except,O
for,O
a,O
higher,O
incidence,O
of,O
DNA,O
aneuploidy,B-DNA_Mutation
by,O
flow,O
cytometry,O
(,O
P,O
=,O
0.001,O
),O
and,O
a,O
lower,O
median,O
of,O
disease,O
-,O
free,O
survival,O
(,O
P,O
=,O
0.06,O
),O
.,O
 , 
Multivariate,O
analysis,O
showed,O
that,O
numerical,B-DNA_Mutation
abnormalities,I-DNA_Mutation
of,O
chromosome,B-locus
17,I-locus
,,I-locus
but,O
not,O
of,O
chromosome,B-locus
18,I-locus
,,I-locus
are,O
an,O
independent,O
prognostic,O
factor,O
for,O
predicting,O
disease,O
-,O
free,O
survival,O
in,O
patients,O
with,O
colorectal,O
cancer,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,B-DNA_Mutation
Numerical,I-DNA_Mutation
abnormalities,I-DNA_Mutation
of,O
chromosomes,B-locus
17,I-locus
and,I-locus
18,I-locus
were,O
relatively,O
common,O
findings,O
in,O
patients,O
with,O
colorectal,O
cancer,O
,,O
with,O
chromosome,B-locus
17,I-locus
being,O
associated,O
with,O
a,O
higher,O
incidence,O
of,O
tumors,O
localized,O
to,O
the,O
rectum,O
and,O
a,O
worse,O
clinical,O
outcome,O
.,O
 , 
Cytometry,O
Part,O
B,O
(,O
Clin,O
.,O
 , 
Cytometry,O
),O
 , 
51B:14,O
-,O
20,O
,,O
2003,O
.,O
 , 

,O
 , 
#15930278
Mutations,B-DNA_Mutation
in,O
two,O
short,O
noncoding,O
mononucleotide,O
repeats,O
in,O
most,O
microsatellite,B-DNA_Mutation
-,I-DNA_Mutation
unstable,I-DNA_Mutation
colorectal,O
cancers,O
.,O
 , 


,O
DNA,O
mismatch,O
repair,O
(,O
MMR)-deficient,O
cells,O
typically,O
accumulate,O
mutations,B-DNA_Mutation
in,O
short,O
repetitive,O
DNA,O
tracts,O
.,O
 , 
This,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
(,B-DNA_Mutation
MSI,I-DNA_Mutation
),I-DNA_Mutation
facilitates,O
malignant,O
transformation,O
when,O
affecting,O
genes,O
with,O
growth,O
-,O
related,O
and,O
caretaker,O
functions,O
.,O
 , 
To,O
date,O
,,O
several,O
putative,O
MSI,B-DNA_Mutation
target,O
genes,O
have,O
been,O
proposed,O
mainly,O
based,O
on,O
high,O
mutation,B-DNA_Mutation
frequency,O
within,O
their,O
coding,O
regions,O
.,O
 , 
However,O
,,O
some,O
intronic,O
repeat,O
mutations,B-DNA_Mutation
have,O
also,O
been,O
suggested,O
to,O
associate,O
with,O
MSI,B-DNA_Mutation
tumorigenesis,O
,,O
indicating,O
the,O
need,O
for,O
additional,O
analyses,O
on,O
noncoding,O
repeats,O
.,O
 , 
Here,O
we,O
have,O
analyzed,O
an,O
intronic,O
T9,O
repeat,O
of,O
semenogelin,B-Gene_protein
I,I-Gene_protein
(,B-Gene_protein
SEMG1,I-Gene_protein
),I-Gene_protein
and,O
report,O
mutation,B-DNA_Mutation
frequencies,O
of,O
51,O
%,O
(,O
75,O
of,O
146,O
),O
and,O
62,O
%,O
(,O
8,O
of,O
13,O
),O
in,O
MMR,O
-,O
deficient,O
primary,O
colorectal,O
cancers,O
and,O
cell,O
lines,O
,,O
respectively,O
.,O
 , 
The,O
putative,O
effect,O
of,O
the,O
SEMG1,B-Gene_protein
mutations,B-DNA_Mutation
was,O
assessed,O
by,O
RNA,O
and,O
protein,O
level,O
analyses,O
,,O
but,O
no,O
differences,O
were,O
detected,O
between,O
colorectal,O
cancer,O
cell,O
lines,O
with,O
different,O
SEMG1,B-Gene_protein
status,O
.,O
 , 
Subsequently,O
,,O
the,O
general,O
background,O
mutation,B-DNA_Mutation
frequency,O
of,O
MSI,B-DNA_Mutation
colorectal,O
cancers,O
was,O
assessed,O
by,O
screening,O
for,O
intergenic,B-locus
T9,I-locus
repeat,I-locus
alterations,B-DNA_Mutation
.,I-DNA_Mutation
 , 
One,O
of,O
10,O
examined,O
repeats,O
was,O
mutated,B-DNA_Mutation
in,O
70,O
%,O
(,O
102,O
of,O
145,O
),O
of,O
the,O
colorectal,O
cancers,O
evaluated,O
.,O
 , 
The,O
frequencies,O
observed,O
here,O
are,O
notably,O
higher,O
than,O
previously,O
published,O
in,O
noncoding,O
repeats,O
shorter,O
than,O
10,O
bp,O
in,O
MMR,O
-,O
deficient,O
primary,O
tumors,O
.,O
 , 
Our,O
results,O
indicate,O
that,O
high,O
mutation,B-DNA_Mutation
frequencies,O
,,O
similar,O
or,O
higher,O
than,O
those,O
observed,O
in,O
proposed,O
and,O
approved,O
target,O
genes,O
,,O
can,O
be,O
detected,O
in,O
repeat,O
tracts,O
of,O
MSI,B-DNA_Mutation
tumors,O
without,O
any,O
apparent,O
selection,O
pressure,O
.,O
 , 
These,O
data,O
call,O
for,O
urgent,O
and,O
thorough,O
large,O
-,O
scale,O
evaluation,O
of,O
mutation,B-DNA_Mutation
frequencies,O
in,O
neutral,O
short,O
repetitive,O
sequences,O
in,O
MMR,O
-,O
deficient,O
tumors,O
.,O
 , 

,O
 , 
#9100840
Frequent,O
alterations,O
in,O
gene,O
expression,O
in,O
colon,O
tumor,O
cells,O
of,O
the,O
microsatellite,O
mutator,O
phenotype,O
.,O
 , 


,O
Tumors,O
of,O
the,O
microsatellite,O
mutator,O
phenotype,O
(,O
MMP,O
),O
are,O
characterized,O
by,O
the,O
accumulation,O
of,O
many,O
thousands,O
of,O
somatic,O
mutations,B-DNA_Mutation
in,O
tracts,O
of,O
simple,O
repeated,O
sequences,O
or,O
microsatellites,O
.,O
 , 
Using,O
arbitrarily,O
primed,O
PCR,O
fingerprinting,O
of,O
RNA,O
(,O
RAP,O
-,O
PCR,O
),O
,,O
we,O
have,O
comparatively,O
analyzed,O
the,O
overall,O
gene,O
expression,O
patterns,O
of,O
several,O
colorectal,O
tumor,O
cell,O
lines,O
with,O
and,O
without,O
the,O
MMP,O
.,O
 , 
A,O
reproducible,O
pattern,O
of,O
30,O
-,O
40,O
main,O
products,O
was,O
obtained,O
for,O
each,O
fingerprint,O
with,O
a,O
total,O
of,O
about,O
200,O
cell,O
transcripts,O
analyzed,O
.,O
 , 
Differences,O
in,O
RAP,O
-,O
PCR,O
fingerprints,O
were,O
detected,O
between,O
these,O
tumor,O
cell,O
lines,O
.,O
 , 
Some,O
of,O
these,O
expression,O
polymorphisms,B-DNA_Mutation
appeared,O
to,O
be,O
specific,O
for,O
tumor,O
cells,O
of,O
the,O
MMP,O
because,O
they,O
were,O
present,O
in,O
two,O
or,O
more,O
different,O
MMP+,O
cell,O
lines,O
but,O
absent,O
in,O
all,O
MMP-,O
cell,O
lines,O
analyzed,O
.,O
 , 
We,O
also,O
analyzed,O
RNAs,O
prepared,O
from,O
single,O
cell,O
clones,O
isolated,O
from,O
these,O
tumor,O
cell,O
lines,O
.,O
 , 
Reproducible,O
differences,O
in,O
the,O
fingerprints,O
were,O
detected,O
between,O
single,O
cell,O
clones,O
from,O
each,O
of,O
the,O
cell,O
lines,O
analyzed,O
.,O
 , 
Examples,O
of,O
single,O
cell,O
clone,O
-,O
specific,O
fingerprint,O
differences,O
from,O
one,O
of,O
the,O
MMP,O
tumor,O
cell,O
lines,O
were,O
cloned,O
and,O
sequenced,O
.,O
 , 
Differential,O
expression,O
of,O
some,O
of,O
these,O
sequences,O
was,O
confirmed,O
by,O
Northern,O
analysis,O
using,O
the,O
cloned,O
fragments,O
as,O
probes,O
.,O
 , 
Similar,O
fingerprint,O
alterations,O
were,O
also,O
observed,O
among,O
single,O
cell,O
clones,O
derived,O
from,O
single,O
cell,O
clones,O
from,O
mutator,O
tumor,O
cell,O
lines,O
,,O
which,O
appeared,O
to,O
exhibit,O
higher,O
clonal,O
variation,B-DNA_Mutation
in,O
gene,O
expression,O
compared,O
with,O
MMP-,O
cells,O
.,O
 , 
The,O
detection,O
of,O
inter-,O
and,O
intra,O
-,O
tumor,O
alterations,O
in,O
gene,O
expression,O
by,O
unbiased,O
RAP,O
-,O
PCR,O
show,O
that,O
these,O
fluctuations,O
occur,O
with,O
high,O
frequency,O
in,O
tumor,O
cells,O
of,O
the,O
MMP,O
.,O
 , 
These,O
results,O
indicate,O
that,O
the,O
profound,O
genomic,B-DNA_Mutation
instability,I-DNA_Mutation
of,O
tumor,O
cells,O
of,O
the,O
MMP,O
is,O
also,O
reflected,O
in,O
a,O
high,O
incidence,O
of,O
alterations,O
in,O
their,O
patterns,O
of,O
gene,O
expression,O
.,O
 , 

,O
 , 
#12579286
Clinicopathologic,O
characteristics,O
related,O
to,O
the,O
high,O
variability,O
of,O
coding,O
mononucleotide,O
repeat,O
sequences,O
in,O
tumors,O
with,O
high,O
-,B-DNA_Mutation
microsatellite,I-DNA_Mutation
instability,I-DNA_Mutation
.,I-DNA_Mutation
 , 


,B-DNA_Mutation
Frameshift,I-DNA_Mutation
mutation,I-DNA_Mutation
at,O
coding,O
mononucleotide,O
repeat,O
sequences,O
are,O
common,O
in,O
tumors,O
with,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
(,B-DNA_Mutation
MSI,I-DNA_Mutation
-,I-DNA_Mutation
H,I-DNA_Mutation
),I-DNA_Mutation
,,O
but,O
the,O
incidences,O
are,O
different,O
among,O
the,O
target,O
genes,O
.,O
 , 
We,O
analyzed,O
the,O
mutational,B-DNA_Mutation
profiles,O
of,O
12,O
known,O
target,O
genes,O
containing,O
polydeoxyadenosine,O
repeats,O
in,O
their,O
coding,O
sequences,O
in,O
39,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
H,I-DNA_Mutation
colorectal,O
carcinomas,O
and,O
40,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
H,I-DNA_Mutation
gastric,O
carcinomas,O
by,O
using,O
polymerase,O
chain,O
reaction,O
and,O
sequencing,O
,,O
and,O
compared,O
the,O
results,O
with,O
the,O
clinicopathologic,O
characteristics,O
.,O
 , 
Frameshift,B-DNA_Mutation
mutations,I-DNA_Mutation
of,O
target,O
genes,O
in,O
the,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
H,I-DNA_Mutation
colorectal,O
and,O
gastric,O
carcinomas,O
are,O
increased,O
according,O
to,O
the,O
length,O
of,O
the,O
polydeoxyadenosine,O
repeats,O
in,O
the,O
target,O
genes,O
.,O
 , 
The,O
mean,O
mutational,B-DNA_Mutation
rates,O
of,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
H,I-DNA_Mutation
colorectal,O
carcinomas,O
and,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
H,I-DNA_Mutation
gastric,O
carcinomas,O
were,O
2.03,O
and,O
1.95,O
in,O
the,O
4,O
genes,O
containing,O
(,O
A)10,O
repeats,O
,,O
1.23,O
and,O
0.73,O
in,O
the,O
4,O
genes,O
with,O
(,O
A)9,O
repeats,O
and,O
0.61,O
and,O
0.48,O
in,O
the,O
4,O
genes,O
containing,O
(,O
A)8,O
repeats,O
,,O
respectively,O
(,O
p<0.001,O
),O
.,O
 , 
Among,O
the,O
evaluated,O
clinicopathologic,O
findings,O
,,O
intestinal,O
type,O
gastric,O
carcinomas,O
had,O
more,O
frameshift,B-DNA_Mutation
mutations,I-DNA_Mutation
than,O
the,O
diffuse,O
type,O
carcinomas,O
(,O
3.5,O
vs.,O
1.9,O
,,O
p=0.01,O
),O
.,O
 , 
These,O
findings,O
suggest,O
that,O
mutational,B-DNA_Mutation
rates,O
of,O
the,O
target,O
genes,O
in,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
H,I-DNA_Mutation
tumors,O
are,O
diverse,O
,,O
and,O
higher,O
mutational,B-DNA_Mutation
rates,O
are,O
related,O
to,O
the,O
length,O
of,O
mononucleotide,O
repeat,O
sequences,O
of,O
the,O
target,O
genes,O
and,O
histologic,O
type,O
of,O
tumors,O
.,O
 , 

,O
 , 
#12574499
PUMA,B-Gene_protein
mediates,O
the,O
apoptotic,O
response,O
to,O
p53,B-Gene_protein
in,O
colorectal,O
cancer,O
cells,O
.,O
 , 


,O
Although,O
several,O
genes,O
that,O
might,O
mediate,O
p53,B-Gene_protein
-,I-Gene_protein
induced,O
apoptosis,O
have,O
been,O
proposed,O
,,O
none,O
have,O
previously,O
been,O
shown,O
to,O
play,O
an,O
essential,O
role,O
in,O
this,O
process,O
through,O
a,O
rigorous,O
gene,O
disruption,O
approach,O
.,O
 , 
We,O
used,O
a,O
gene,O
-,O
targeting,O
approach,O
to,O
evaluate,O
p53,B-Gene_protein
-,I-Gene_protein
mediated,O
death,O
in,O
human,O
colorectal,O
cancer,O
cells,O
.,O
 , 
Expression,O
of,O
p53,B-Gene_protein
in,O
these,O
cells,O
induces,O
growth,O
arrest,O
through,O
transcriptional,O
activation,O
of,O
the,O
cyclin,O
-,O
dependent,O
kinase,O
inhibitor,O
p21,B-Gene_protein
.,I-Gene_protein
 , 
If,O
p21,B-Gene_protein
is,O
disrupted,O
via,O
gene,O
targeting,O
,,O
the,O
cells,O
die,O
through,O
apoptosis,O
.,O
 , 
If,O
the,O
PUMA,B-Gene_protein
gene,O
is,O
also,O
disrupted,O
in,O
such,O
cells,O
,,O
apoptosis,O
is,O
prevented,O
.,O
 , 
The,O
effects,O
of,O
PUMA,B-Gene_protein
on,O
apoptosis,O
were,O
observed,O
after,O
exogenous,O
overexpression,O
of,O
p53,B-Gene_protein
as,O
well,O
as,O
after,O
exposure,O
to,O
hypoxia,O
,,O
a,O
physiologic,O
activator,O
of,O
p53,B-Gene_protein
,,I-Gene_protein
and,O
DNA,B-DNA_Mutation
damage,I-DNA_Mutation
.,I-DNA_Mutation
 , 
The,O
PUMA,B-Gene_protein
protein,O
interacts,O
with,O
Bcl,B-Gene_protein
-,I-Gene_protein
X(L,I-Gene_protein
),I-Gene_protein
and,O
promotes,O
mitochondrial,O
translocation,O
and,O
multimerization,O
of,O
Bax,B-Gene_protein
.,I-Gene_protein
 , 
Accordingly,O
,,O
genetic,O
disruption,O
of,O
BAX,B-Gene_protein
makes,O
cells,O
resistant,O
to,O
the,O
apoptosis,O
resulting,O
from,O
PUMA,B-Gene_protein
expression,O
.,O
 , 
These,O
results,O
suggest,O
that,O
the,O
balance,O
between,O
PUMA,B-Gene_protein
and,O
p21,B-Gene_protein
is,O
pivotal,O
in,O
determining,O
the,O
responses,O
to,O
p53,B-Gene_protein
activation,O
and,O
provide,O
a,O
model,O
for,O
understanding,O
the,O
basis,O
of,O
p53,B-Gene_protein
mutations,B-DNA_Mutation
in,O
human,O
cancer,O
.,O
 , 

,O
 , 
#15598787
Polymorphism,B-DNA_Mutation
in,O
the,O
thymidylate,B-Gene_protein
synthase,I-Gene_protein
promoter,B-locus
enhancer,I-locus
region,O
and,O
risk,O
of,O
colorectal,O
adenomas,O
.,O
 , 


,B-Gene_protein
Thymidylate,I-Gene_protein
synthase,I-Gene_protein
(,B-Gene_protein
TS,I-Gene_protein
),I-Gene_protein
,,O
a,O
key,O
one,O
-,O
carbon,O
metabolizing,O
gene,O
,,O
encodes,O
an,O
enzyme,O
that,O
converts,O
dUMP,O
to,O
dTMP,O
,,O
the,O
rate,O
-,O
limiting,O
nucleotide,O
in,O
DNA,O
synthesis,O
.,O
 , 
We,O
recently,O
reported,O
that,O
a,O
promoter,B-locus
polymorphism,B-DNA_Mutation
in,O
TS,B-Gene_protein
modified,O
the,O
risk,O
of,O
colorectal,O
cancer,O
as,O
well,O
as,O
the,O
survival,O
rate,O
after,O
the,O
disease,O
.,O
 , 
To,O
explore,O
whether,O
TS,B-Gene_protein
may,O
play,O
an,O
important,O
role,O
in,O
colorectal,O
carcinogenesis,O
early,O
in,O
the,O
multistaged,O
pathogenic,O
pathway,O
,,O
we,O
investigated,O
the,O
relation,O
between,O
the,O
TS,B-Gene_protein
promoter,B-locus
polymorphism,B-DNA_Mutation
and,O
risk,O
of,O
colorectal,O
adenoma,O
in,O
a,O
nested,O
case,O
-,O
control,O
study,O
within,O
the,O
prospective,O
Health,O
Professionals,O
Follow,O
-,O
up,O
Study,O
.,O
 , 
We,O
ascertained,O
the,O
TS,B-Gene_protein
genotype,O
from,O
373,O
incident,O
colorectal,O
adenoma,O
cases,O
and,O
720,O
control,O
subjects,O
.,O
 , 
Although,O
there,O
was,O
no,O
overall,O
association,O
between,O
the,O
TS,B-Gene_protein
promoter,B-locus
polymorphism,B-DNA_Mutation
and,O
adenoma,O
risk,O
,,O
we,O
observed,O
a,O
significant,O
TS,B-Gene_protein
-,I-Gene_protein
alcohol,O
interaction,O
(,O
P,O
for,O
interaction,O
=,O
0.009,O
),O
;,O
 , 
relative,O
to,O
low,O
alcohol,O
consumers,O
with,O
the,O
2R/2R,O
genotype,O
,,O
those,O
with,O
high,O
alcohol,O
consumption,O
(,O
>,O
30,O
g,O
/,O
d,O
),O
were,O
not,O
at,O
elevated,O
risk,O
if,O
they,O
had,O
the,O
2R/2R,O
genotype,O
 , 
[,O
relative,O
risk,O
(,O
RR,O
),O
,,O
0.80,O
;,O
95,O
%,O
confidence,O
interval,O
(,O
95,O
%,O
CI,O
),O
,,O
0.34,O
-,O
1.90,O
],O
,,O
but,O
were,O
at,O
higher,O
risk,O
if,O
they,O
had,O
the,O
2R/3R,O
genotype,O
(,O
RR,O
,,O
1.70,O
;,O
95,O
%,O
CI,O
,,O
0.87,O
-,O
3.31,O
),O
,,O
and,O
at,O
the,O
highest,O
risk,O
(,O
RR,O
,,O
3.16,O
;,O
95,O
%,O
CI,O
,,O
1.50,O
-,O
6.63,O
),O
if,O
they,O
had,O
the,O
3R/3R,O
genotype,O
.,O
 , 
In,O
addition,O
,,O
a,O
significant,O
interaction,O
was,O
observed,O
between,O
the,O
TS,B-Gene_protein
promoter,B-locus
polymorphism,B-DNA_Mutation
and,O
the,O
677C,B-DNA_Mutation
>,I-DNA_Mutation
T,I-DNA_Mutation
polymorphism,B-DNA_Mutation
of,O
methylenetetrahydrofolate,B-Gene_protein
reductase,I-Gene_protein
(,B-Gene_protein
MTHFR,I-Gene_protein
;,I-Gene_protein
P,O
for,O
interaction,O
=,O
0.007,O
),O
.,O
 , 
These,O
findings,O
lend,O
additional,O
support,O
that,O
one,O
-,O
carbon,O
metabolism,O
is,O
an,O
important,O
process,O
in,O
pathogenesis,O
of,O
colorectal,O
cancer,O
.,O
 , 

,O
 , 
#24375840
Correlation,O
of,O
dynamic,O
contrast,O
-,O
enhanced,O
MRI,O
perfusion,O
parameters,O
with,O
angiogenesis,O
and,O
biologic,O
aggressiveness,O
of,O
rectal,O
cancer,O
:,O
Preliminary,O
results,O
.,O
 , 



,O
#,O
#,O
PURPOSE,O

,O
To,O
investigate,O
whether,O
quantitative,O
parameters,O
derived,O
from,O
dynamic,O
contrast,O
-,O
enhanced,O
magnetic,O
resonance,O
imaging,O
(,O
DCE,O
-,O
MRI,O
),O
are,O
correlated,O
with,O
angiogenesis,O
and,O
biologic,O
aggressiveness,O
of,O
rectal,O
cancer,O
.,O
 , 


,O
#,O
#,O
MATERIALS,O
AND,O
METHODS,O

,O
A,O
total,O
of,O
46,O
patients,O
with,O
rectal,O
cancer,O
underwent,O
DCE,O
-,O
MRI,O
.,O
 , 
Using,O
a,O
two,O
-,O
compartmental,O
model,O
,,O
quantitative,O
parameters,O
(,O
K(trans,O
),O
,,O
kep,O
,,O
ve,O
,,O
and,O
iAUC,O
),O
were,O
calculated,O
from,O
the,O
whole,O
-,O
transverse,O
region,O
of,O
interest,O
(,O
ROI,O
),O
and,O
high,O
K(trans,O
),O
area,O
ROI,O
of,O
entire,O
tumors,O
.,O
 , 
Histological,O
specimens,O
were,O
analyzed,O
for,O
tumor,O
size,O
;,O
T,O
/,O
N,O
stage,O
;,O
lymphatic,O
,,O
vascular,O
,,O
perineural,O
invasion,O
;,O
expression,O
of,O
epidermal,B-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
receptor,I-Gene_protein
(,B-Gene_protein
EGFR,I-Gene_protein
),I-Gene_protein
;,O
and,O
KRAS,B-Gene_protein
gene,O
mutations,B-DNA_Mutation
.,I-DNA_Mutation
 , 
Tumor,O
angiogenesis,O
was,O
evaluated,O
based,O
on,O
the,O
microvessel,O
density,O
(,O
MVD,O
),O
and,O
the,O
expression,O
level,O
of,O
the,O
vascular,B-Gene_protein
endothelial,I-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
.,I-Gene_protein
 , 
Correlations,O
of,O
the,O
DCE,O
-,O
MRI,O
parameters,O
with,O
histological,O
markers,O
and,O
angiogenesis,O
were,O
determined,O
using,O
Student,O
's,O
t,O
-,O
test,O
and,O
analysis,O
of,O
variance,O
(,O
ANOVA,O
),O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
The,O
mean,O
kep,O
from,O
high,O
K(trans,O
),O
area,O
ROIs,O
showed,O
a,O
significantly,O
positive,O
correlation,O
with,O
MVD,O
(,O
P,O
  ,O
=,O
 , 
 ,O
0.030,O
,,O
r,O
  ,O
=,O
 , 
 ,O
0.514,O
,,O
R(2,O
),O
  ,O
=,O
 , 
 ,O
0.264,O
),O
.,O
 , 
The,O
mean,O
kep,O
from,O
the,O
whole,O
-,O
transverse,O
ROIs,O
showed,O
a,O
significant,O
inverse,O
correlation,O
with,O
T,O
stage,O
(,O
T1,O
vs.,O
T2,O
-,O
4,O
,,O
P,O
  ,O
=,O
 , 
 ,O
0.021,O
),O
.,O
 , 
EGFR,B-Gene_protein
-,I-Gene_protein
positive,O
cancer,O
displayed,O
higher,O
mean,O
K(trans,O
),O
(,O
P,O
  ,O
=,O
 ,O
0.045,O
),O
and,O
kep,O
(,O
P,O
  ,O
=,O
 , 
 ,O
0.038,O
),O
than,O
EGFR,B-Gene_protein
-,I-Gene_protein
negative,O
cancer,O
in,O
whole,O
-,O
transverse,O
ROIs,O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
 , 
These,O
preliminary,O
results,O
suggest,O
that,O
the,O
determination,O
of,O
kep,O
of,O
high,O
K(trans,O
),O
area,O
permits,O
the,O
noninvasive,O
estimation,O
of,O
tumor,O
angiogenesis,O
in,O
rectal,O
cancer,O
and,O
that,O
DCE,O
-,O
MRI,O
parameters,O
can,O
be,O
used,O
as,O
imaging,O
biomarkers,O
to,O
predict,O
the,O
biologic,O
aggressiveness,O
of,O
the,O
tumor,O
and,O
patient,O
prognosis,O
.,O

,O
 , 
#1568571
The,O
relationship,O
of,O
DNA,O
aneuploidy,B-DNA_Mutation
to,O
molecular,O
genetic,B-DNA_Mutation
alterations,I-DNA_Mutation
in,O
colorectal,O
carcinoma,O
.,O
 , 


,O
Altered,O
total,O
nuclear,O
DNA,O
content,O
is,O
frequent,O
in,O
colorectal,O
carcinomas,O
,,O
but,O
the,O
mechanisms,O
producing,O
aneuploidy,B-DNA_Mutation
are,O
unknown,O
.,O
 , 
Therefore,O
,,O
DNA,O
ploidy,O
by,O
flow,O
cytometry,O
was,O
correlated,O
with,O
molecular,O
genetic,B-DNA_Mutation
alterations,I-DNA_Mutation
and,O
tumor,O
characteristics,O
in,O
50,O
colorectal,O
carcinomas,O
.,O
 , 
The,O
prognostic,O
value,O
of,O
these,O
alterations,O
was,O
also,O
evaluated,O
because,O
aneuploidy,B-DNA_Mutation
has,O
been,O
associated,O
with,O
poor,O
prognosis,O
.,O
 , 
Thirty,O
-,O
nine,O
of,O
the,O
carcinomas,O
(,O
78,O
%,O
),O
were,O
DNA,O
aneuploid,B-DNA_Mutation
.,I-DNA_Mutation
 , 
When,O
compared,O
with,O
diploid,O
carcinomas,O
,,O
aneuploid,B-DNA_Mutation
tumors,O
had,O
greater,O
mean,O
fractional,O
allelic,O
loss,O
,,O
defined,O
as,O
the,O
fraction,O
of,O
evaluable,O
nonacrocentric,O
autosomal,O
arms,O
with,O
deletion,B-DNA_Mutation
(,O
0.25,O
+,O
/-,O
0.15,O
,,O
range,O
0,O
-,O
0.667,O
,,O
vs.,O
0.12,O
+,O
/-,O
0.10,O
,,O
range,O
0,O
-,O
0.345,O
;,O
 , 
P,O
=,O
0.006,O
),O
.,O
 , 
DNA,O
index,O
by,O
flow,O
cytometry,O
correlated,O
with,O
fractional,O
allelic,B-DNA_Mutation
loss,I-DNA_Mutation
(,O
r,O
=,O
0.38,O
,,O
P,O
=,O
0.006,O
),O
.,O
 , 
Aneuploid,B-DNA_Mutation
tumors,O
also,O
had,O
more,O
frequent,O
allelic,B-DNA_Mutation
loss,I-DNA_Mutation
on,O
chromosome,B-locus
17p,I-locus
(,O
87,O
%,O
vs.,O
55,O
%,O
;,O
P,O
=,O
0.017,O
),O
,,O
but,O
less,O
frequent,O
ras,O
gene,O
mutation,B-DNA_Mutation
(,O
44,O
%,O
vs.,O
82,O
%,O
;,O
P,O
=,O
0.025,O
),O
.,O
 , 
Among,O
the,O
25,O
right,O
-,O
sided,O
and,O
25,O
left,O
-,O
sided,O
tumors,O
,,O
DNA,O
diploid,O
tumors,O
were,O
more,O
frequent,O
on,O
the,O
right,O
side,O
(,O
P,O
=,O
0.002,O
),O
,,O
whereas,O
deletion,B-DNA_Mutation
of,O
17p,B-locus
was,O
found,O
predominantly,O
on,O
the,O
left,O
side,O
.,O
 , 
Aneuploidy,O
was,O
associated,O
with,O
moderate,O
and,O
poor,O
differentiation,O
of,O
the,O
carcinomas,O
but,O
not,O
with,O
distant,O
metastasis,O
.,O
 , 
By,O
contrast,O
,,O
high,O
fractional,O
allelic,B-DNA_Mutation
loss,I-DNA_Mutation
,,I-DNA_Mutation
deletion,B-DNA_Mutation
of,O
17p,B-locus
,,I-locus
and,O
deletion,B-DNA_Mutation
of,O
18q,B-locus
were,O
associated,O
with,O
distant,O
metastasis,O
.,O
 , 
In,O
survival,O
analysis,O
of,O
patients,O
with,O
Dukes,O
',O
B,O
or,O
C,O
carcinoma,O
,,O
DNA,O
aneuploidy,B-DNA_Mutation
was,O
not,O
a,O
significant,O
discriminator,O
,,O
but,O
patients,O
whose,O
tumor,O
had,O
deletion,B-DNA_Mutation
of,O
17p,B-locus
or,O
deletion,B-DNA_Mutation
of,O
both,O
17p,B-locus
and,O
18q,B-locus
had,O
poorer,O
survival,O
(,O
P,O
=,O
0.045,O
and,O
0.022,O
,,O
respectively,O
),O
.,O
 , 
The,O
results,O
suggest,O
that,O
DNA,O
aneuploidy,B-DNA_Mutation
is,O
associated,O
with,O
some,O
of,O
the,O
molecular,O
genetic,B-DNA_Mutation
alterations,I-DNA_Mutation
and,O
phenotypic,O
characteristics,O
of,O
colorectal,O
carcinomas,O
but,O
is,O
not,O
a,O
reliable,O
indicator,O
of,O
metastatic,O
potential,O
.,O

,O
 , 
#2843422
[,O
Assessment,O
of,O
the,O
risk,O
of,O
recurrence,O
isolated,O
cases,O
of,O
dominantly,O
inherited,O
diseases,O
with,O
incomplete,O
penetrance,O
and,O
age,O
-,O
related,O
dependence,O
],O
.,O
 , 


,O
A,O
modification,O
of,O
the,O
method,O
for,O
risk,O
estimation,O
in,O
isolated,O
cases,O
of,O
autosomal,O
dominant,O
disorders,O
with,O
reduced,O
penetrance,O
is,O
presented,O
.,O
 , 
It,O
is,O
based,O
on,O
the,O
Bayesian,O
theorem,O
and,O
considers,O
such,O
parameters,O
as,O
fitness,O
,,O
age,O
-,O
specific,O
expressivity,O
of,O
the,O
gene,O
and,O
the,O
effect,O
of,O
parental,O
age,O
on,O
mutation,B-DNA_Mutation
rate,O
.,O
 , 
The,O
definite,O
expression,O
of,O
the,O
risk,O
estimation,O
is,O
proposed,O
.,O
 , 
Using,O
hereditary,O
polyposis,O
as,O
an,O
example,O
,,O
possible,O
risks,O
are,O
proposed,O
.,O
 , 
The,O
table,O
of,O
risks,O
,,O
depending,O
on,O
the,O
parental,O
age,O
,,O
is,O
given,O
.,O
 , 

,O
 , 
#8646513
Synchronous,O
colon,O
carcinomas,O
:,O
molecular,O
-,O
genetic,O
evidence,O
for,O
multicentricity,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
 , 
The,O
synchronous,O
presentation,O
of,O
multiple,O
colonic,O
adenocarcinomas,O
is,O
an,O
unusual,O
,,O
but,O
well,O
-,O
recognized,O
event,O
accounting,O
for,O
approximately,O
2,O
-,O
11,O
%,O
of,O
these,O
neoplasms,O
.,O
 , 
Synchronous,O
tumors,O
may,O
have,O
a,O
different,O
biology,O
and,O
prognosis,O
than,O
solitary,O
tumors,O
.,O
 , 
Evidence,O
based,O
on,O
measurement,O
of,O
DNA,O
ploidy,O
suggests,O
that,O
a,O
significant,O
percentage,O
of,O
synchronous,O
tumors,O
have,O
a,O
common,O
clonal,O
origin,O
,,O
probably,O
resulting,O
from,O
translumenal,O
metastasis,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
Fifteen,O
synchronous,O
colorectal,O
cancers,O
(,O
30,O
tumors,O
),O
were,O
examined,O
for,O
histologic,O
differences,O
as,O
well,O
as,O
genetic,O
mutations,B-DNA_Mutation
.,I-DNA_Mutation
 , 
p53,B-Gene_protein
gene,O
abnormalities,B-DNA_Mutation
were,O
detected,O
by,O
polymerase,O
chain,O
reaction,O
(,O
PCR,O
),O
followed,O
by,O
single,O
-,O
strand,O
conformation,O
polymorphism,O
analysis,O
.,O
 , 
Ki,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
mutations,B-DNA_Mutation
were,O
detected,O
by,O
PCR,O
followed,O
by,O
oligonucleotide,O
-,O
specific,O
hybridization,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,B-Gene_protein
p53,I-Gene_protein
gene,O
mutations,B-DNA_Mutation
were,O
detected,O
in,O
12,O
of,O
30,O
tumors,O
.,O
 , 
In,O
only,O
one,O
case,O
was,O
the,O
same,O
p53,B-Gene_protein
mutation,B-DNA_Mutation
present,O
in,O
both,O
tumors,O
from,O
one,O
patient,O
.,O
 , 
Similarly,O
,,O
Ki,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
mutations,B-DNA_Mutation
were,O
observed,O
in,O
9,O
of,O
30,O
tumors,O
.,O
 , 
Concordant,O
Ki,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
mutations,B-DNA_Mutation
were,O
observed,O
in,O
only,O
one,O
case,O
,,O
which,O
was,O
also,O
concordant,O
for,O
p53,B-Gene_protein
mutation,B-DNA_Mutation
.,I-DNA_Mutation
 , 


,O
#,O
#,O
CONCLUSION,O

,O
 , 
Because,O
p53,B-Gene_protein
and,O
Ki,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
mutations,B-DNA_Mutation
tend,O
to,O
occur,O
fairly,O
early,O
in,O
tumor,O
development,O
,,O
it,O
seems,O
likely,O
that,O
cases,O
discordant,O
for,O
p53,B-Gene_protein
and,O
Ki,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
mutations,B-DNA_Mutation
represent,O
independently,O
developing,O
tumor,O
foci,O
.,O
 , 
Taken,O
together,O
,,O
these,O
findings,O
strongly,O
suggest,O
that,O
the,O
great,O
majority,O
of,O
synchronous,O
colonic,O
adenocarcinomas,O
arise,O
as,O
independent,O
neoplasms,O
and,O
their,O
worsened,O
prognosis,O
is,O
not,O
a,O
result,O
of,O
unusually,O
early,O
metastatic,O
spread,O
.,O
 , 

,O
 , 
#10090594
Loss,B-DNA_Mutation
of,I-DNA_Mutation
heterozygosity,I-DNA_Mutation
of,O
APC,B-Gene_protein
and,O
DCC,B-Gene_protein
tumor,O
suppressor,O
genes,O
in,O
human,O
sporadic,O
colon,O
cancer,O
.,O
 , 


,O
We,O
examined,O
36,O
cases,O
of,O
human,O
sporadic,O
colon,O
carcinoma,O
and,O
corresponding,O
normal,O
tissue,O
samples,O
to,O
evaluate,O
loss,B-DNA_Mutation
of,I-DNA_Mutation
heterozygosity,I-DNA_Mutation
at,O
the,O
APC,B-Gene_protein
and,O
DCC,B-Gene_protein
tumor,O
suppressor,O
genes,O
loci,O
using,O
restriction,O
fragment,O
length,O
polymorphism,O
polymerase,O
chain,O
reaction,O
and,O
variable,O
nucleotide,O
tandem,O
repeat,O
analysis,O
.,O
 , 
Observed,O
informativity,O
was,O
83,O
%,O
for,O
APC,B-Gene_protein
and,O
75,O
%,O
for,O
DCC,B-Gene_protein
.,I-Gene_protein
 , 
DNA,O
from,O
6,O
(,O
20,O
%,O
),O
of,O
30,O
informative,O
tumors,O
exhibited,O
loss,B-DNA_Mutation
of,I-DNA_Mutation
heterozygosity,I-DNA_Mutation
at,O
the,O
APC,B-Gene_protein
locus,O
.,O
 , 
Loss,B-DNA_Mutation
of,I-DNA_Mutation
heterozygosity,I-DNA_Mutation
at,O
the,O
DCC,B-Gene_protein
locus,O
was,O
observed,O
in,O
7,O
(,O
26,O
%,O
),O
of,O
27,O
informative,O
tumor,O
DNAs,O
.,O
 , 
Our,O
results,O
support,O
the,O
view,O
that,O
malignant,O
progression,O
is,O
a,O
consequence,O
of,O
more,O
than,O
one,O
genetic,B-DNA_Mutation
change,I-DNA_Mutation
and,O
suggest,O
that,O
inactivation,O
of,O
APC,B-Gene_protein
and,O
DCC,B-Gene_protein
genes,O
plays,O
a,O
role,O
in,O
a,O
multistep,O
process,O
of,O
colon,O
tumor,O
progression,O
.,O
 , 

,O
 , 
#8381331
Frequent,O
multiplication,B-DNA_Mutation
of,O
the,O
long,B-locus
arm,I-locus
of,O
chromosome,B-locus
8,I-locus
in,O
hepatocellular,O
carcinoma,O
.,O
 , 


,O
Frequent,O
allelic,B-DNA_Mutation
losses,I-DNA_Mutation
at,O
loci,O
on,O
several,O
chromosomes,O
have,O
been,O
detected,O
in,O
human,O
hepatocellular,O
carcinomas,O
,,O
but,O
other,O
types,O
of,O
chromosomal,O
abnormalities,O
have,O
not,O
been,O
characterized,O
well,O
.,O
 , 
Using,O
eight,O
polymorphic,O
DNA,O
markers,O
on,O
chromosome,B-locus
8,I-locus
,,I-locus
we,O
examined,O
120,O
primary,O
hepatocellular,O
carcinomas,O
for,O
abnormalities,B-DNA_Mutation
in,O
the,O
copy,O
number,O
of,O
these,O
loci,O
in,O
tumor,O
cells,O
.,O
 , 
A,O
2-,O
to,O
6,O
-,O
fold,O
increase,O
in,O
intensities,O
of,O
bands,O
representing,O
single,O
alleles,O
was,O
observed,O
in,O
32,O
of,O
the,O
78,O
tumors,O
that,O
were,O
informative,O
for,O
one,O
or,O
more,O
of,O
the,O
markers,O
,,O
indicating,O
an,O
increase,B-DNA_Mutation
in,I-DNA_Mutation
copy,I-DNA_Mutation
number,I-DNA_Mutation
(,O
",B-DNA_Mutation
multiplication,I-DNA_Mutation
",I-DNA_Mutation
),O
of,O
alleles,O
on,O
8q,B-locus
.,I-locus
 , 
The,O
regions,O
that,O
multiplied,B-DNA_Mutation
varied,O
from,O
almost,O
the,O
entire,O
long,B-locus
arm,I-locus
to,O
a,O
distal,O
segment,O
of,O
chromosome,B-locus
8,I-locus
,,I-locus
but,O
a,O
terminal,O
region,O
distal,O
to,O
8q24.11,B-locus
was,O
multiplied,O
in,O
all,O
32,O
cases,O
.,O
 , 
Similar,O
multiplications,B-DNA_Mutation
on,O
8q,B-locus
were,O
detected,O
in,O
nine,O
of,O
56,O
colorectal,O
carcinomas,O
that,O
were,O
informative,O
for,O
one,O
or,O
more,O
of,O
the,O
markers,O
.,O
 , 
Our,O
study,O
demonstrated,O
that,O
polymorphic,O
DNA,O
markers,O
can,O
be,O
used,O
to,O
detect,O
numerical,O
abnormalities,B-DNA_Mutation
of,O
chromosomal,O
material,O
in,O
solid,O
tumors,O
in,O
which,O
cytogenetic,O
analysis,O
is,O
technically,O
difficult,O
.,O
 , 

,O
 , 
#21387463
Deciphering,O
the,O
colon,O
cancer,O
genes,O
--,O
report,O
of,O
the,O
InSiGHT,O
-,O
Human,O
Variome,O
Project,O
Workshop,O
,,O
UNESCO,O
,,O
Paris,O
2010,O
.,O
 , 


,O
The,O
Human,O
Variome,O
Project,O
(,O
HVP,O
),O
has,O
established,O
a,O
pilot,O
program,O
with,O
the,O
International,O
Society,O
for,O
Gastrointestinal,O
Hereditary,O
Tumours,O
(,O
InSiGHT,O
),O
to,O
compile,O
all,O
inherited,O
variation,B-DNA_Mutation
affecting,O
colon,O
cancer,O
susceptibility,O
genes,O
.,O
 , 
An,O
HVP,O
-,O
InSiGHT,O
Workshop,O
was,O
held,O
on,O
May,O
10,O
,,O
2010,O
,,O
prior,O
to,O
the,O
HVP,O
Integration,O
and,O
Implementation,O
Meeting,O
at,O
UNESCO,O
in,O
Paris,O
,,O
to,O
review,O
the,O
progress,O
of,O
this,O
pilot,O
program,O
.,O
 , 
A,O
wide,O
range,O
of,O
topics,O
were,O
covered,O
,,O
including,O
issues,O
relating,O
to,O
genotype,O
-,O
phenotype,O
data,O
submission,O
to,O
the,O
InSiGHT,O
Colon,O
Cancer,O
Gene,O
Variant,B-DNA_Mutation
Databases,O
(,O
chromium.liacs.nl/LOVD2/colon_cancer/home.php,O
),O
.,O
 , 
The,O
meeting,O
also,O
canvassed,O
the,O
recent,O
exciting,O
developments,O
in,O
models,O
to,O
evaluate,O
the,O
pathogenicity,O
of,O
unclassified,O
variants,B-DNA_Mutation
using,O
in,O
silico,O
data,O
,,O
tumor,O
pathology,O
information,O
,,O
and,O
functional,O
assays,O
,,O
and,O
made,O
further,O
plans,O
for,O
the,O
future,O
progress,O
and,O
sustainability,O
of,O
the,O
pilot,O
program,O
.,O
 , 

,O
 , 
#17990317
Novel,O
mutant,B-DNA_Mutation
-,I-DNA_Mutation
enriched,O
sequencing,O
identified,O
high,O
frequency,O
of,O
PIK3CA,B-Gene_protein
mutations,B-DNA_Mutation
in,O
pharyngeal,O
cancer,O
.,O
 , 


,O
We,O
previously,O
reported,O
4,O
PIK3CA,B-Gene_protein
mutations,B-DNA_Mutation
in,O
38,O
head,O
and,O
neck,O
cancer,O
samples,O
,,O
3,O
of,O
which,O
were,O
identified,O
in,O
6,O
pharyngeal,O
cancer,O
samples,O
.,O
 , 
To,O
determine,O
the,O
mutation,B-DNA_Mutation
frequency,O
of,O
PIK3CA,B-Gene_protein
in,O
pharyngeal,O
cancer,O
,,O
we,O
studied,O
24,O
additional,O
cases,O
of,O
pharyngeal,O
squamous,O
cell,O
carcinoma,O
in,O
this,O
study,O
.,O
 , 
Using,O
both,O
direct,O
genomic,O
DNA,O
sequencing,O
and,O
novel,O
mutant,O
-,O
enriched,O
sequencing,O
methods,O
developed,O
specifically,O
for,O
the,O
3,O
hot,O
-,O
spot,O
mutations,B-Protein_Mutation
(,B-Protein_Mutation
H1047R,I-Protein_Mutation
,,I-Protein_Mutation
E545,B-Protein_Mutation
K,I-Protein_Mutation
and,O
E452,B-Protein_Mutation
K,I-Protein_Mutation
),I-Protein_Mutation
of,O
PIK3CA,B-Gene_protein
,,I-Gene_protein
we,O
detected,O
5,O
mutations,B-DNA_Mutation
of,O
PIK3CA,B-Gene_protein
in,O
the,O
24,O
pharyngeal,O
cancers,O
(,O
20.8,O
%,O
),O
.,O
 , 
Three,O
of,O
the,O
5,O
mutations,B-DNA_Mutation
had,O
been,O
missed,O
by,O
the,O
conventional,O
sequencing,O
method,O
and,O
were,O
subsequently,O
detected,O
by,O
novel,O
mutant,O
-,O
enriched,O
sequencing,O
methods,O
.,O
 , 
We,O
showed,O
that,O
the,O
mutant,O
-,O
enriched,O
sequencing,O
method,O
for,O
the,O
H1047R,B-Protein_Mutation
hot,O
-,O
spot,O
mutation,B-DNA_Mutation
can,O
identify,O
the,O
mutation,B-DNA_Mutation
in,O
a,O
mixed,O
population,O
of,O
mutant,B-DNA_Mutation
and,O
wild,O
-,O
type,O
DNA,O
sequences,O
at,O
1:360,O
ratios,O
.,O
 , 
These,O
novel,O
mutant,O
-,O
enriched,O
sequencing,O
methods,O
allow,O
the,O
detection,O
of,O
the,O
PIK3CA,B-Gene_protein
hot,O
-,O
spot,O
mutations,B-DNA_Mutation
in,O
clinical,O
specimens,O
which,O
often,O
contain,O
limited,O
tumor,O
tissues,O
(,O
i.e.,O
,,O
biopsy,O
specimens,O
),O
.,O
 , 
The,O
data,O
further,O
support,O
that,O
oncogenic,O
PIK3CA,B-Gene_protein
may,O
play,O
a,O
critical,O
role,O
in,O
pharyngeal,O
carcinogenesis,O
,,O
and,O
the,O
mutant,O
-,O
enriched,O
sequencing,O
methods,O
for,O
PIK3CA,B-Gene_protein
are,O
sensitive,O
and,O
reliable,O
ways,O
to,O
detect,O
PIK3CA,B-Gene_protein
mutations,B-DNA_Mutation
in,O
clinical,O
samples,O
.,O
 , 
Because,O
PIK3CA,B-Gene_protein
and,O
its,O
pathway,O
are,O
potential,O
targets,O
for,O
chemotherapy,O
and,O
radiation,O
therapy,O
,,O
and,O
frequent,O
somatic,O
mutation,B-DNA_Mutation
of,O
PIK3CA,B-Gene_protein
has,O
been,O
identified,O
in,O
many,O
human,O
cancer,O
types,O
(,O
e.g.,O
,,O
breast,O
cancer,O
,,O
colorectal,O
cancer,O
),O
,,O
the,O
abilities,O
to,O
detect,O
PIK3CA,B-Gene_protein
mutations,B-DNA_Mutation
with,O
enhanced,O
sensitivities,O
have,O
great,O
potential,O
impacts,O
on,O
target,O
therapies,O
for,O
many,O
cancer,O
types,O
.,O
 , 

,O
 , 
#16636019
Identification,O
of,O
mismatch,O
repair,O
gene,O
mutations,B-DNA_Mutation
in,O
young,O
patients,O
with,O
colorectal,O
cancer,O
and,O
in,O
patients,O
with,O
multiple,O
tumours,O
associated,O
with,O
hereditary,O
non,O
-,O
polyposis,O
colorectal,O
cancer,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,O
Patients,O
with,O
early,O
-,O
onset,O
colorectal,O
cancer,O
(,O
CRC,O
),O
or,O
those,O
with,O
multiple,O
tumours,O
associated,O
with,O
hereditary,O
non,O
-,O
polyposis,O
colorectal,O
cancer,O
(,O
HNPCC,O
),O
raise,O
suspicion,O
of,O
the,O
presence,O
of,O
germline,O
DNA,O
mismatch,O
repair,O
(,O
MMR,O
),O
gene,O
mutations,B-DNA_Mutation
.,I-DNA_Mutation
 , 


,O
#,O
#,O
AIM,O

,O
To,O
analyse,O
the,O
value,O
of,O
family,O
history,O
,,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
(,B-DNA_Mutation
MSI,I-DNA_Mutation
),I-DNA_Mutation
analysis,O
and,O
MMR,O
protein,O
staining,O
in,O
the,O
tumour,O
to,O
predict,O
the,O
presence,O
of,O
an,O
MMR,O
gene,O
mutation,B-DNA_Mutation
in,O
such,O
patients,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
 , 
In,O
281,O
patients,O
diagnosed,O
with,O
CRC,O
before,O
the,O
age,O
of,O
50,O
years,O
or,O
with,O
CRC,O
and,O
at,O
least,O
one,O
additional,O
HNPCC,O
-,O
associated,O
cancer,O
,,O
germline,O
mutation,B-DNA_Mutation
analysis,O
in,O
MLH1,B-Gene_protein
,,I-Gene_protein
MSH2,B-Gene_protein
and,O
MSH6,B-Gene_protein
was,O
carried,O
out,O
with,O
denaturing,O
gradient,O
gel,O
electrophoresis,O
and,O
multiplex,O
ligation,O
-,O
dependent,O
probe,O
amplification,O
.,O
 , 
MSI,B-DNA_Mutation
analysis,O
with,O
five,O
consensus,O
markers,O
and,O
MMR,O
protein,O
staining,O
for,O
MLH1,B-Gene_protein
,,I-Gene_protein
MSH2,B-Gene_protein
and,O
MSH6,B-Gene_protein
were,O
carried,O
out,O
in,O
the,O
tumours,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
25,O
pathogenic,O
mutations,B-DNA_Mutation
(,O
8,O
in,O
MLH1,B-Gene_protein
,,I-Gene_protein
9,O
in,O
MSH2,B-Gene_protein
and,O
8,O
in,O
MSH6,B-Gene_protein
),I-Gene_protein
were,O
found,O
.,O
 , 
MSI,B-DNA_Mutation
analysis,O
missed,O
three,O
and,O
immunohistochemistry,O
(,O
IHC,O
),O
missed,O
two,O
mutation,B-DNA_Mutation
carriers,O
.,O
 , 
Sensitivities,O
of,O
family,O
history,O
,,O
MSI,B-DNA_Mutation
analysis,O
and,O
IHC,O
for,O
the,O
presence,O
of,O
a,O
mutation,B-DNA_Mutation
were,O
76,O
%,O
,,O
82,O
%,O
and,O
88,O
%,O
,,O
specificities,O
were,O
64,O
%,O
,,O
70,O
%,O
and,O
84,O
%,O
,,O
and,O
positive,O
predictive,O
values,O
were,O
19,O
%,O
,,O
23,O
%,O
and,O
38,O
%,O
,,O
respectively,O
.,O
 , 
Multivariate,O
analysis,O
showed,O
the,O
highest,O
odds,O
ratio,O
for,O
IHC,O
(,O
38.3,O
,,O
95,O
%,O
confidence,O
interval,O
9.0,O
to,O
184,O
),O
.,O
 , 
Prevalence,O
of,O
pathogenic,O
germline,O
MMR,O
gene,O
mutations,B-DNA_Mutation
in,O
patients,O
with,O
CRC,O
before,O
the,O
age,O
of,O
50,O
years,O
was,O
6,O
%,O
and,O
in,O
those,O
with,O
>,O
or,O
=,O
2,O
HNPCC,O
-,O
associated,O
tumours,O
was,O
22,O
%,O
.,O
 , 
In,O
the,O
second,O
group,O
,,O
no,O
mutation,B-DNA_Mutation
carriers,O
were,O
found,O
among,O
the,O
29,O
patients,O
who,O
were,O
diagnosed,O
with,O
their,O
first,O
tumour,O
after,O
the,O
age,O
of,O
60,O
years,O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
Family,O
history,O
,,O
MSI,B-DNA_Mutation
analysis,O
and,O
IHC,O
are,O
indicative,O
parameters,O
to,O
select,O
patients,O
with,O
CRC,O
for,O
MMR,O
gene,O
mutation,B-DNA_Mutation
analysis,O
.,O
 , 
The,O
data,O
show,O
that,O
IHC,O
is,O
the,O
best,O
single,O
selection,O
criterion,O
.,O
 , 

,O
 , 
#21734379
Nutritional,O
influences,O
in,O
selected,O
gastrointestinal,O
diseases,O
.,O
 , 


,O
Nutritional,O
factors,O
,,O
as,O
sources,O
of,O
luminal,O
antigens,O
,,O
have,O
been,O
thought,O
to,O
be,O
important,O
factors,O
in,O
the,O
immunopathogenesis,O
of,O
numerous,O
gastrointestinal,O
diseases,O
.,O
 , 
In,O
some,O
diseases,O
,,O
the,O
role,O
of,O
the,O
nutritional,O
component,O
is,O
causal,O
in,O
the,O
susceptible,O
host,O
.,O
 , 
Such,O
diseases,O
include,O
celiac,O
disease,O
,,O
a,O
common,O
heritable,O
chronic,O
inflammatory,O
condition,O
of,O
the,O
small,O
intestine,O
induced,O
by,O
dietary,O
wheat,O
,,O
rye,O
and,O
barley,O
,,O
in,O
susceptible,O
individuals,O
.,O
 , 
Specific,O
HLA,B-locus
-,I-locus
DQ2,I-locus
and,O
HLA,B-locus
-,I-locus
DQ8,I-locus
risk,O
alleles,O
are,O
necessary,O
,,O
but,O
not,O
sufficient,O
,,O
for,O
disease,O
development,O
.,O
 , 
The,O
well,O
-,O
defined,O
role,O
of,O
HLA,B-locus
-,I-locus
DQ,I-locus
heterodimers,O
encoded,O
by,O
these,O
alleles,O
is,O
to,O
present,O
cereal,O
peptides,O
to,O
CD4,B-Gene_protein
+,I-Gene_protein
T,O
cells,O
,,O
activating,O
an,O
inflammatory,O
immune,O
response,O
in,O
the,O
intestine,O
.,O
 , 
Genome,O
-,O
wide,O
association,O
studies,O
have,O
been,O
performed,O
which,O
identified,O
the,O
IL2,B-Gene_protein
-,I-Gene_protein
IL21,I-Gene_protein
risk,O
locus,O
and,O
other,O
genes,O
with,O
immune,O
functions,O
and,O
key,O
roles,O
in,O
thymic,O
T,O
-,O
cell,O
selection,O
.,O
 , 
Another,O
example,O
for,O
this,O
group,O
is,O
Wilson,O
's,O
disease,O
,,O
an,O
autosomal,O
recessive,O
disorder,O
of,O
copper,O
metabolism,O
caused,O
by,O
mutation,B-DNA_Mutation
of,O
the,O
ATP7B,B-Gene_protein
gene,O
,,O
resulting,O
in,O
a,O
defect,O
of,O
biliary,O
copper,O
excretion,O
and,O
toxic,O
accumulation,O
in,O
the,O
body,O
,,O
especially,O
in,O
the,O
liver,O
,,O
brain,O
and,O
cornea,O
,,O
resulting,O
in,O
hepatic,O
and/or,O
neurological,O
symptoms,O
.,O
 , 
In,O
other,O
diseases,O
,,O
however,O
,,O
the,O
association,O
is,O
less,O
well,O
established,O
.,O
 , 
In,O
such,O
endeavor,O
,,O
epidemiological,O
observations,O
may,O
become,O
a,O
valuable,O
part,O
of,O
the,O
overall,O
investigations,O
aimed,O
at,O
identifying,O
dietary,O
factors,O
,,O
which,O
are,O
involved,O
in,O
the,O
initiation,O
and,O
perpetuation,O
of,O
the,O
specific,O
disease,O
.,O
 , 
As,O
an,O
example,O
,,O
relationships,O
between,O
nutrition,O
and,O
colorectal,O
cancer,O
have,O
been,O
hypothesized,O
early,O
on,O
(,O
e.g.,O
folate,O
,,O
calcium,O
,,O
vitamin,O
D,O
,,O
red,O
meat,O
),O
.,O
 , 
Similarly,O
,,O
intake,O
of,O
certain,O
diet,O
constituents,O
like,O
fat,O
,,O
refined,O
sugar,O
,,O
fruits,O
,,O
vegetables,O
and,O
fiber,O
was,O
reported,O
to,O
be,O
associated,O
with,O
the,O
expression,O
of,O
inflammatory,O
bowel,O
diseases,O
.,O
 , 
In,O
addition,O
,,O
in,O
children,O
with,O
active,O
Crohn,O
's,O
disease,O
,,O
enteral,O
nutrition,O
was,O
found,O
to,O
be,O
equally,O
effective,O
as,O
corticosteroids,O
in,O
induction,O
of,O
remission,O
,,O
with,O
mucosal,O
healing,O
induced,O
by,O
downregulation,O
of,O
mucosal,O
pro,O
-,O
inflammatory,O
cytokine,O
profiles,O
in,O
both,O
the,O
ileum,O
and,O
the,O
colon,O
after,O
enteral,O
nutrition,O
.,O
 , 
However,O
,,O
the,O
particular,O
effect,O
of,O
the,O
consumption,O
of,O
each,O
type,O
of,O
food,O
remains,O
questionable,O
in,O
most,O
cases,O
,,O
at,O
least,O
in,O
part,O
because,O
of,O
insufficient,O
data,O
and,O
serious,O
methodological,O
limitations,O
(,O
e.g.,O
recall,O
bias,O
,,O
heterogeneity,O
between,O
collected,O
data,O
,,O
lack,O
of,O
correction,O
for,O
covariates,O
,,O
difficulties,O
in,O
double,O
blinding,O
),O
.,O
 , 

,O
 , 
#14522894
Microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
is,O
a,O
predictive,O
factor,O
of,O
the,O
tumor,O
response,O
to,O
irinotecan,O
in,O
patients,O
with,O
advanced,O
colorectal,O
cancer,O
.,O
 , 


,O
The,O
aim,O
of,O
our,O
study,O
was,O
to,O
assess,O
the,O
relationship,O
between,O
colorectal,O
tumor,O
responsiveness,O
to,O
irinotecan,O
and,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
(,B-DNA_Mutation
MSI,I-DNA_Mutation
),I-DNA_Mutation
,,O
a,O
feature,O
of,O
colorectal,O
tumors,O
with,O
DNA,O
mismatch,O
repair,O
defect,O
.,O
 , 
Seventy,O
-,O
two,O
patients,O
with,O
metastatic,O
colorectal,O
cancer,O
were,O
included,O
in,O
our,O
retrospective,O
study,O
.,O
 , 
A,O
complete,O
response,O
to,O
irinotecan,O
was,O
observed,O
in,O
1,O
patient,O
and,O
a,O
partial,O
response,O
in,O
10,O
patients,O
,,O
whereas,O
61,O
patients,O
did,O
not,O
respond,O
to,O
this,O
treatment,O
.,O
 , 
We,O
analyzed,O
the,O
protein,O
expression,O
of,O
hMLH1,B-Gene_protein
,,I-Gene_protein
hMSH2,B-Gene_protein
,,I-Gene_protein
and,O
BAX,B-Gene_protein
by,O
immunohistochemistry,O
,,O
determined,O
the,O
MSI,B-DNA_Mutation
phenotype,O
,,O
and,O
looked,O
for,O
mutations,B-DNA_Mutation
in,O
the,O
coding,O
repeats,O
located,O
in,O
the,O
transforming,O
growth,O
factor,O
beta,B-Gene_protein
-,I-Gene_protein
RII,I-Gene_protein
,,I-Gene_protein
BAX,B-Gene_protein
,,I-Gene_protein
hMSH3,B-Gene_protein
,,I-Gene_protein
and,O
hMSH6,B-Gene_protein
genes,O
.,O
 , 
All,O
44,O
tumors,O
analyzed,O
expressed,O
detectable,O
levels,O
of,O
hMLH1,B-Gene_protein
;,I-Gene_protein
1,O
tumor,O
lacked,O
hMSH2,B-Gene_protein
staining,O
,,O
whereas,O
4,O
tumors,O
showed,O
a,O
marked,O
decrease,O
in,O
BAX,B-Gene_protein
expression,O
.,O
 , 
A,O
better,O
response,O
to,O
irinotecan,O
was,O
observed,O
in,O
the,O
patients,O
whose,O
tumors,O
have,O
lost,O
BAX,B-Gene_protein
expression,O
(,O
P,O
<,O
0.001,O
),O
.,O
 , 
Among,O
the,O
7,O
tumors,O
that,O
displayed,O
a,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
H,I-DNA_Mutation
phenotype,O
,,O
4,O
responded,O
to,O
irinotecan,O
,,O
whereas,O
only,O
7,O
of,O
the,O
65,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
L/,I-DNA_Mutation
microsatellite,O
stable,O
tumors,O
did,O
(,O
P,O
=,O
0.009,O
),O
.,O
 , 
Seven,O
of,O
the,O
72,O
tumors,O
had,O
inactivating,O
mutations,B-DNA_Mutation
in,O
the,O
coding,O
repeats,O
of,O
the,O
target,O
genes,O
.,O
 , 
Three,O
tumors,O
displayed,O
a,O
mutation,B-DNA_Mutation
in,O
the,O
poly,B-locus
-,I-locus
A10,I-locus
tract,O
of,O
the,O
transforming,B-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
beta,I-Gene_protein
-,I-Gene_protein
RII,I-Gene_protein
gene,O
,,O
associated,O
with,O
a,O
1,O
-,O
bp,O
deletion,B-DNA_Mutation
in,O
the,O
poly,B-locus
-,I-locus
A8,I-locus
tract,O
of,O
hMSH3,B-Gene_protein
in,O
one,O
tumor,O
and,O
with,O
a,O
1,O
-,O
bp,O
deletion,B-DNA_Mutation
in,O
the,O
poly,B-locus
-,I-locus
G8,I-locus
tract,O
of,O
BAX,B-Gene_protein
in,O
another,O
.,O
 , 
Four,O
tumors,O
displayed,O
mutations,B-DNA_Mutation
in,O
the,O
poly,B-locus
-,I-locus
G8,I-locus
repeat,O
of,O
BAX,B-Gene_protein
,,I-Gene_protein
whereas,O
2,O
mutations,B-DNA_Mutation
in,O
hMSH6,B-Gene_protein
and,O
hMSH3,B-Gene_protein
were,O
characterized,O
.,O
 , 
Among,O
the,O
7,O
tumors,O
with,O
mutations,B-DNA_Mutation
in,O
these,O
target,O
genes,O
,,O
5,O
responded,O
to,O
irinotecan,O
,,O
whereas,O
only,O
6,O
of,O
the,O
other,O
65,O
tumors,O
did,O
(,O
P,O
<,O
0.001,O
),O
,,O
indicating,O
that,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
driven,O
inactivation,O
of,O
target,O
genes,O
modifies,O
tumor,O
chemosensitivity,O
.,O
 , 
Our,O
observations,O
allowed,O
us,O
to,O
define,O
the,O
first,O
useful,O
predictive,O
criteria,O
for,O
irinotecan,O
response,O
in,O
patients,O
with,O
colorectal,O
cancer,O
.,O
 , 

,O
 , 
#15782113
Partial,O
downregulation,O
of,O
MAD1,B-Gene_protein
causes,O
spindle,O
checkpoint,O
inactivation,O
and,O
aneuploidy,B-DNA_Mutation
,,I-DNA_Mutation
but,O
does,O
not,O
confer,O
resistance,O
towards,O
taxol,O
.,O
 , 


,O
The,O
mitotic,O
spindle,O
assembly,O
checkpoint,O
ensures,O
proper,O
chromosome,O
segregation,O
during,O
mitosis,O
by,O
inhibiting,O
the,O
onset,O
of,O
anaphase,O
until,O
all,O
kinetochores,O
are,O
attached,O
to,O
the,O
mitotic,O
spindle,O
and,O
tension,O
across,O
the,O
kinetochores,O
is,O
generated,O
.,O
 , 
Here,O
,,O
we,O
report,O
that,O
the,O
stable,O
partial,O
downregulation,O
of,O
the,O
spindle,O
checkpoint,O
gene,O
MAD1,B-Gene_protein
,,I-Gene_protein
which,O
is,O
observed,O
in,O
human,O
cancer,O
,,O
leads,O
to,O
a,O
functional,O
inactivation,O
of,O
the,O
spindle,O
checkpoint,O
resulting,O
in,O
gross,O
aneuploidy,B-DNA_Mutation
.,I-DNA_Mutation
 , 
Interestingly,O
,,O
although,O
Mad1,B-Gene_protein
is,O
thought,O
to,O
act,O
as,O
a,O
kinetochore,O
based,O
activator,O
of,O
Mad2,B-Gene_protein
during,O
checkpoint,O
activation,O
,,O
we,O
show,O
that,O
normal,O
levels,O
of,O
Mad2,B-Gene_protein
,,I-Gene_protein
but,O
not,O
of,O
Mad1,B-Gene_protein
,,I-Gene_protein
are,O
required,O
for,O
preventing,O
premature,O
sister,O
chromatid,O
separation,O
and,O
for,O
maintaining,O
the,O
timing,O
of,O
an,O
undisturbed,O
mitosis,O
,,O
suggesting,O
a,O
Mad1,B-Gene_protein
independent,O
function,O
of,O
Mad2,B-Gene_protein
that,O
operates,O
independent,O
of,O
its,O
checkpoint,O
function,O
.,O
 , 
Most,O
significantly,O
,,O
a,O
partial,O
repression,O
of,O
either,O
MAD1,B-Gene_protein
or,O
MAD2,B-Gene_protein
confers,O
resistance,O
to,O
nocodazole,O
,,O
a,O
drug,O
that,O
inhibits,O
microtubule,O
attachment,O
.,O
 , 
In,O
contrast,O
,,O
sensitivity,O
to,O
clinically,O
relevant,O
drugs,O
like,O
taxol,O
or,O
monastrol,O
that,O
inhibit,O
the,O
generation,O
of,O
tension,O
across,O
kinetochores,O
is,O
not,O
modulated,O
by,O
partial,O
downregulation,O
of,O
MAD1,B-Gene_protein
,,I-Gene_protein
suggesting,O
a,O
functional,O
bifurcation,O
of,O
spindle,O
checkpoint,O
dependent,O
apoptotic,O
pathways,O
.,O
 , 

,O
 , 
#19443375
Microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
does,O
not,O
predict,O
the,O
efficacy,O
of,O
chemotherapy,O
in,O
metastatic,O
colorectal,O
cancer,O
.,O
 , 
A,O
systematic,O
review,O
and,O
meta,O
-,O
analysis,O
.,O
 , 



,O
#,O
#,O
BACKGROUND,O

,B-DNA_Mutation
Microsatellite,I-DNA_Mutation
Instability,I-DNA_Mutation
(,B-DNA_Mutation
MSI,I-DNA_Mutation
),I-DNA_Mutation
status,O
is,O
a,O
good,O
prognostic,O
factor,O
for,O
colorectal,O
cancer,O
(,O
CRC,O
),O
but,O
its,O
predictive,O
value,O
for,O
chemosensitivity,O
remains,O
controversial,O
.,O
 , 
A,O
previous,O
meta,O
-,O
analysis,O
(,O
MA,O
),O
in,O
the,O
adjuvant,O
setting,O
showed,O
that,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
high,O
(,O
H,O
),O
status,O
did,O
not,O
predict,O
the,O
efficacy,O
of,O
chemotherapy,O
.,O
 , 
The,O
predictive,O
value,O
of,O
MSI,B-DNA_Mutation
status,O
on,O
the,O
effect,O
of,O
metastatic,O
chemotherapy,O
was,O
investigated,O
by,O
MA,O
.,O
 , 


,O
#,O
#,O
PATIENTS,O
AND,O
METHODS,O

,O
Studies,O
were,O
identified,O
by,O
electronic,O
search,O
through,O
PubMed,O
,,O
Embase,O
and,O
ASCO,O
proceedings,O
online,O
databases,O
,,O
using,O
several,O
key,O
words,O
(,O
colorectal,O
cancer,O
,,O
chemotherapy,O
,,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
),I-DNA_Mutation
.,O
 , 
For,O
each,O
study,O
,,O
the,O
ratio,O
of,O
response,O
rate,O
(,O
RR,O
),O
,,O
complete,O
(,O
CR,O
),O
and,O
partial,O
response,O
(,O
PR,O
),O
divided,O
by,O
stable,O
disease,O
and,O
progression,O
was,O
calculated,O
.,O
 , 
From,O
190,O
articles,O
and,O
100,O
abstracts,O
,,O
only,O
eight,O
independent,O
studies,O
were,O
selected,O
.,O
 , 
The,O
data,O
were,O
analysed,O
with,O
a,O
random,O
-,O
effect,O
model,O
(,O
due,O
to,O
heterogeneity,O
between,O
studies,O
),O
using,O
EasyMA,O
software,O
.,O
 , 
Statistical,O
calculations,O
were,O
performed,O
on,O
six,O
studies,O
representing,O
964,O
patients,O
(,O
mean,O
age,O
63,O
years,O
;,O
91,O
MSI,O
-,O
H,O
;,O
873,O
microsatellite,O
stable,O
(,O
MSS,O
),O
tumours,O
),O
.,O
 , 
A,O
total,O
of,O
287,O
patients,O
received,O
5,O
-,O
fluorouracil,O
(,O
5FU)-based,O
chemotherapy,O
,,O
whereas,O
678,O
patients,O
received,O
combinations,O
of,O
5FU,O
or,O
capecitabine,O
with,O
oxaliplatin,O
and/or,O
irinotecan,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
No,O
benefit,O
of,O
metastatic,O
chemotherapy,O
in,O
terms,O
of,O
RR,O
for,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
H,O
patients,O
compared,O
with,O
MSS,O
patients,O
was,O
found,O
.,O
 , 
The,O
global,O
hazard,O
ratio,O
(,O
HR,O
),O
for,O
RR,O
was,O
0.82,O
(,O
95,O
%,O
confidence,O
interval,O
,,O
CI,O
:,O
0.95,O
;,O
0.65,O
-,O
1.03,O
;,O
p=0.09,O
),O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,B-DNA_Mutation
MSI,I-DNA_Mutation
status,O
does,O
not,O
predict,O
the,O
effect,O
of,O
chemotherapy,O
which,O
is,O
similar,O
in,O
MSI,B-DNA_Mutation
-,I-DNA_Mutation
H,O
and,O
MSS,O
metastatic,O
CRC,O
tumours,O
.,O
 , 

,O
 , 
#21115420
[,O
Colorectal,O
oncogenesis,O
],O
.,O
 , 


,O
Recent,O
progress,O
in,O
the,O
field,O
of,O
molecular,O
biology,O
has,O
allowed,O
us,O
to,O
identify,O
at,O
least,O
two,O
different,O
molecular,O
mechanisms,O
implicated,O
in,O
colorectal,O
carcinogenesis,O
(,O
CRC,O
):,O
chromosomal,B-DNA_Mutation
instability,I-DNA_Mutation
(,B-DNA_Mutation
CIN,I-DNA_Mutation
),I-DNA_Mutation
and,O
genetic,B-DNA_Mutation
instability,I-DNA_Mutation
.,I-DNA_Mutation
 , 
Even,O
though,O
the,O
two,O
molecular,O
mechanisms,O
differ,O
,,O
their,O
signalling,O
pathways,O
,,O
implicated,O
in,O
malignant,O
transformation,O
of,O
colonic,O
epithelial,O
cells,O
,,O
appear,O
to,O
be,O
similar,O
.,O
 , 
The,O
most,O
frequent,O
group,O
of,O
CRC,O
,,O
which,O
represents,O
80,O
%,O
of,O
sporadic,O
CRC,O
,,O
is,O
characterized,O
by,O
allelic,O
losses,B-DNA_Mutation
on,O
the,O
short,B-locus
arm,I-locus
of,I-locus
chromosome,I-locus
17,I-locus
and,I-locus
8,I-locus
and,O
on,O
the,O
long,B-locus
arm,I-locus
of,I-locus
chromosome,I-locus
5,I-locus
,,I-locus
18,I-locus
and,I-locus
22,I-locus
.,I-locus
 , 
These,O
allelic,O
losses,B-DNA_Mutation
are,O
associated,O
with,O
mutations,B-DNA_Mutation
in,O
TP53,B-Gene_protein
,,I-Gene_protein
APC,B-Gene_protein
,,I-Gene_protein
SMAD2,B-Gene_protein
and,O
SMAD4,B-Gene_protein
genes,O
.,O
 , 
All,O
of,O
these,O
alterations,O
are,O
grouped,O
under,O
the,O
phenotype,O
CIN,B-DNA_Mutation
.,I-DNA_Mutation
 , 
A,O
 ,B-DNA_Mutation
genetic,I-DNA_Mutation
instability,I-DNA_Mutation
termed,O
MSI,B-DNA_Mutation
(,B-DNA_Mutation
microsatellite,I-DNA_Mutation
instability,I-DNA_Mutation
),I-DNA_Mutation
,,O
which,O
results,O
from,O
a,O
mismatch,O
repair,O
(,O
MMR,O
),O
deficiency,O
,,O
appears,O
in,O
12,O
-,O
15,O
%,O
of,O
CRC,O
cases,O
.,O
 , 
The,O
presence,O
of,O
MMR,O
deficiency,O
leads,O
to,O
the,O
accumulation,O
of,O
mutations,B-DNA_Mutation
in,O
genes,O
controlling,O
cell,O
cycle,O
and,O
apoptosis,O
(,B-Gene_protein
TGFBRII,I-Gene_protein
,,I-Gene_protein
BAX,B-Gene_protein
or,O
CASPASE5,B-Gene_protein
),I-Gene_protein
.,O
 , 
More,O
recently,O
,,O
the,O
existence,O
of,O
a,O
third,O
phenotype,O
was,O
suggested,O
.,O
 , 
The,O
main,O
alteration,O
associated,O
with,O
this,O
group,O
of,O
tumors,O
is,O
the,O
hypermethylation,B-DNA_modification
of,O
the,O
promoter,B-locus
region,I-locus
of,O
numerous,O
genes,O
,,O
leading,O
to,O
their,O
inactivation,O
.,O
 , 
An,O
activating,O
mutation,B-DNA_Mutation
of,O
BRAF,B-Gene_protein
is,O
frequently,O
associated,O
with,O
this,O
phenotype,O
.,O
 , 
As,O
described,O
above,O
,,O
CRC,O
shows,O
genetic,O
heterogeneity,O
,,O
however,O
the,O
consequences,O
in,O
terms,O
of,O
signalling,O
pathway,O
alterations,O
are,O
similar,O
.,O
 , 
For,O
example,O
,,O
the,O
activation,O
of,O
Wnt,O
signalling,O
pathways,O
can,O
result,O
from,O
the,O
inactivation,O
of,O
the,O
APC,B-Gene_protein
gene,O
in,O
the,O
CIN,B-DNA_Mutation
phenotype,O
or,O
from,O
an,O
activating,O
mutation,B-DNA_Mutation
in,O
the,O
β,B-Gene_protein
-,I-Gene_protein
catenin,I-Gene_protein
gene,O
in,O
MSI,B-DNA_Mutation
tumors,O
.,O
 , 
The,O
inactivation,O
of,O
TGFβ,B-Gene_protein
pathways,O
is,O
also,O
present,O
in,O
both,O
tumor,O
types,O
and,O
is,O
driven,O
by,O
SMAD4,B-Gene_protein
,,I-Gene_protein
and,O
more,O
rarely,O
by,O
a,O
SMAD2,B-Gene_protein
inactivating,O
mutation,B-DNA_Mutation
in,O
CIN,B-DNA_Mutation
tumors,O
,,O
or,O
by,O
the,O
existence,O
of,O
a,O
frame,B-DNA_Mutation
-,I-DNA_Mutation
shift,I-DNA_Mutation
mutation,I-DNA_Mutation
occurring,O
in,O
a,O
polyG,B-locus
coding,I-locus
track,I-locus
of,O
the,O
TGFβ,B-Gene_protein
(,I-Gene_protein
transforming,I-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
),I-Gene_protein
receptor,I-Gene_protein
type,I-Gene_protein
II,I-Gene_protein
in,O
MSI,B-DNA_Mutation
tumors,O
.,O
 , 
The,O
RAS,O
-,B-Gene_protein
MAP,I-Gene_protein
kinase,I-Gene_protein
pathway,O
is,O
activated,O
by,O
KRAS,B-Gene_protein
mutations,B-DNA_Mutation
in,O
CIN,B-DNA_Mutation
tumors,O
or,O
by,O
BRAF,B-Gene_protein
mutations,B-DNA_Mutation
in,O
MSI,B-DNA_Mutation
tumors,O
.,O
 , 
The,O
p53,B-Gene_protein
pathway,O
is,O
inactivated,O
by,O
TP53,B-Gene_protein
inactivation,O
in,O
CIN,B-DNA_Mutation
tumors,O
or,O
by,O
BAX,B-Gene_protein
inactivating,O
mutations,B-DNA_Mutation
in,O
MSI,B-DNA_Mutation
tumors,O
.,O
 , 

,O
 , 
#21412012
Clinical,O
significance,O
of,O
genetic,B-DNA_Mutation
variations,I-DNA_Mutation
in,O
the,O
PI3K,B-Gene_protein
/,B-Gene_protein
PTEN,I-Gene_protein
/,B-Gene_protein
AKT,I-Gene_protein
/,B-Gene_protein
mTOR,I-Gene_protein
pathway,O
in,O
Korean,O
patients,O
with,O
colorectal,O
cancer,O
.,O
 , 



,O
#,O
#,O
OBJECTIVE,O

,O
Signaling,O
through,O
the,O
PI3K,B-Gene_protein
/,I-Gene_protein
PTEN,I-Gene_protein
/,B-Gene_protein
AKT,I-Gene_protein
/,I-Gene_protein
mTOR,I-Gene_protein
pathway,O
is,O
responsible,O
for,O
balancing,O
cell,O
survival,O
and,O
apoptosis,O
.,O
 , 
Accordingly,O
,,O
the,O
present,O
study,O
analyzed,O
14,O
SNPs,B-DNA_Mutation
of,O
the,O
PI3K,B-Gene_protein
/,I-Gene_protein
PTEN,I-Gene_protein
/,B-Gene_protein
AKT,I-Gene_protein
/,I-Gene_protein
mTOR,I-Gene_protein
pathway,O
genes,O
and,O
their,O
impact,O
on,O
the,O
prognosis,O
for,O
patients,O
with,O
colorectal,O
cancer,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
444,O
consecutive,O
patients,O
with,O
surgically,O
resected,O
colorectal,O
adenocarcinoma,O
were,O
enrolled,O
in,O
the,O
present,O
study,O
.,O
 , 
The,O
genomic,O
DNA,O
was,O
extracted,O
from,O
fresh,O
colorectal,O
tissue,O
,,O
and,O
14,O
polymorphisms,B-DNA_Mutation
of,O
the,O
PI3K,B-Gene_protein
/,B-Gene_protein
PTEN,I-Gene_protein
/,B-Gene_protein
AKT,I-Gene_protein
/,B-Gene_protein
mTOR,I-Gene_protein
pathway,O
genes,O
were,O
determined,O
using,O
a,O
real,O
-,O
time,O
PCR,O
genotyping,O
assay,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
Pathologic,O
stages,O
after,O
surgery,O
were,O
as,O
follows,O
:,O
stage,O
0,O
/,O
I,O
(,O
n,O
=,O
85,O
,,O
19.1,O
%,O
),O
,,O
stage,O
II,O
(,O
n,O
=,O
149,O
,,O
33.6,O
%,O
),O
,,O
stage,O
III,O
(,O
n,O
=,O
147,O
,,O
33.1,O
%,O
),O
,,O
and,O
stage,O
IV,O
(,O
n,O
=,O
63,O
,,O
14.2,O
%,O
),O
.,O
 , 
Univariate,O
and,O
multivariate,O
survival,O
analysis,O
including,O
stage,O
,,O
age,O
,,O
site,O
of,O
disease,O
,,O
adjuvant,O
chemotherapy,O
,,O
and,O
carcinoembryonic,O
antigen,O
(,O
CEA,O
),O
level,O
showed,O
that,O
these,O
polymorphisms,B-DNA_Mutation
were,O
not,O
associated,O
with,O
progression,O
-,O
free,O
or,O
overall,O
survival,O
.,O
 , 
For,O
the,O
clinicopathologic,O
parameters,O
,,O
CEA,O
level,O
and,O
TNM,O
stage,O
were,O
significant,O
prognostic,O
factors,O
in,O
a,O
Cox,O
model,O
for,O
survival,O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
 , 
None,O
of,O
the,O
14,O
SNPs,B-DNA_Mutation
of,O
the,O
PI3K,B-Gene_protein
/,I-Gene_protein
PTEN,I-Gene_protein
/,B-Gene_protein
AKT,I-Gene_protein
/,I-Gene_protein
mTOR,I-Gene_protein
pathway,O
genes,O
investigated,O
in,O
this,O
study,O
was,O
found,O
to,O
be,O
an,O
independent,O
prognostic,O
marker,O
for,O
Korean,O
patients,O
with,O
surgically,O
resected,O
colorectal,O
cancer,O
.,O
 , 

,O
 , 
#15133848
Loss,B-DNA_Mutation
of,I-DNA_Mutation
heterozygosity,I-DNA_Mutation
on,O
chromosome,B-locus
1,I-locus
in,O
sporadic,O
colorectal,O
carcinoma,O
.,O
 , 



,O
#,O
#,O
AIM,O

,B-DNA_Mutation
Loss,I-DNA_Mutation
of,I-DNA_Mutation
heterozygosity,I-DNA_Mutation
(,B-DNA_Mutation
LOH,I-DNA_Mutation
),I-DNA_Mutation
on,O
tumor,O
suppressor,O
genes,O
is,O
believed,O
to,O
play,O
a,O
key,O
role,O
in,O
carcinogenesis,O
of,O
colorectal,O
cancer,O
.,O
 , 
When,O
it,O
occurs,O
at,O
a,O
tumor,O
suppressor,O
gene,O
locus,O
with,O
abnormal,B-DNA_Mutation
allele,I-DNA_Mutation
,,I-DNA_Mutation
neoplastic,O
transformation,O
happens,O
.,O
 , 
In,O
this,O
study,O
,,O
we,O
analyzed,O
the,O
LOH,B-DNA_Mutation
at,O
21,O
loci,O
on,O
chromosome,B-locus
1,I-locus
in,O
sporadic,O
colorectal,O
cancer,O
to,O
identify,O
additional,O
loci,O
involved,O
in,O
colorectal,O
tumorigenesis,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
Twenty,O
-,O
one,O
polymorphic,B-DNA_Mutation
micro,B-locus
-,I-locus
satellite,I-locus
DNA,I-locus
markers,O
were,O
analyzed,O
with,O
PCR,O
both,O
in,O
83,O
cases,O
of,O
colorectal,O
cancer,O
and,O
in,O
normal,O
tissues,O
.,O
 , 
PCR,O
products,O
were,O
eletrophoresed,O
on,O
an,O
ABI,O
377,O
DNA,O
sequencer,O
.,O
 , 
Genescan,O
3.1,O
and,O
Genotype,O
2.1,O
software,O
were,O
used,O
for,O
LOH,B-DNA_Mutation
scanning,O
and,O
analysis,O
.,O
 , 
chi2,O
test,O
was,O
used,O
to,O
compare,O
LOH,B-DNA_Mutation
frequency,O
with,O
clinicopathological,O
data,O
.,O
 , 
P<0.05,O
was,O
considered,O
as,O
statistically,O
significant,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
 , 
The,O
average,O
LOH,B-DNA_Mutation
frequency,O
of,O
chromosome,B-locus
1,I-locus
,,I-locus
short,I-locus
arm,I-locus
and,I-locus
long,I-locus
arm,I-locus
was,O
19.83,O
%,O
,,O
18.00,O
%,O
and,O
21.66,O
%,O
,,O
respectively,O
.,O
 , 
The,O
2,O
highest,O
LOH,B-DNA_Mutation
loci,O
with,O
a,O
frequency,O
of,O
36.54,O
%,O
and,O
32.50,O
%,O
were,O
identified,O
on,O
D1S468,B-locus
(,B-locus
1p36.33,I-locus
-,I-locus
p36.31,I-locus
),I-locus
and,O
D1S413,B-locus
(,B-locus
1q31.3,I-locus
),I-locus
,,O
respectively,O
.,O
 , 
On,O
D1S2726,B-locus
locus,O
,,O
LOH,B-DNA_Mutation
frequency,O
of,O
rectal,O
cancer,O
was,O
28.57,O
%,O
(,O
6/21,O
),O
,,O
which,O
was,O
higher,O
than,O
that,O
of,O
colon,O
cancer,O
(,O
0.00,O
%,O
,,O
0/33,O
),O
(,O
P=0.002,O
),O
,,O
suggesting,O
that,O
the,O
mechanism,O
of,O
carcinogenesis,O
was,O
different,O
in,O
both,O
groups,O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
Putative,O
tumor,O
suppressor,O
genes,O
on,O
chromosome,B-locus
1,I-locus
may,O
relate,O
to,O
sporadic,O
colorectal,O
carcinomas,O
.,O
 , 
Tumor,O
-,O
suppressor,O
-,O
genes,O
might,O
locate,O
on,O
1p36.33,B-locus
-,I-locus
36.31,I-locus
and/or,O
1q31.3,B-locus
.,I-locus
 , 

,O
 , 
#24375256
A,O
genetic,B-DNA_Mutation
variant,I-DNA_Mutation
in,O
microRNA,O
target,O
site,O
of,O
TGF,B-Gene_protein
-,I-Gene_protein
β,I-Gene_protein
signaling,O
pathway,O
increases,O
the,O
risk,O
of,O
colorectal,O
cancer,O
in,O
a,O
Chinese,O
population,O
.,O
 , 


,O
Evidence,O
shows,O
that,O
single,B-DNA_Mutation
-,I-DNA_Mutation
nucleotide,I-DNA_Mutation
polymorphisms,I-DNA_Mutation
in,O
microRNA,O
(,B-locus
miRNA,I-locus
),I-locus
target,I-locus
sites,I-locus
can,O
create,O
,,O
destroy,O
,,O
or,O
modify,O
the,O
miRNA,O
/,O
mRNA,O
binding,O
,,O
therefore,O
modulating,O
gene,O
expression,O
and,O
affecting,O
cancer,O
susceptibility,O
.,O
 , 
The,O
transforming,B-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
-,I-Gene_protein
β,I-Gene_protein
(,B-Gene_protein
TGF,I-Gene_protein
-,I-Gene_protein
β,I-Gene_protein
),I-Gene_protein
signaling,O
pathway,O
plays,O
a,O
pivotal,O
role,O
in,O
tumor,O
initiation,O
and,O
progression,O
.,O
 , 
Intriguingly,O
,,O
recent,O
advances,O
of,O
genome,O
-,O
wide,O
association,O
studies,O
have,O
identified,O
multiple,O
risk,O
loci,O
in,O
this,O
pathway,O
to,O
be,O
associated,O
with,O
risk,O
of,O
colorectal,O
cancer,O
(,O
CRC,O
),O
.,O
 , 
To,O
test,O
the,O
hypothesis,O
that,O
genetic,B-DNA_Mutation
variants,I-DNA_Mutation
in,O
miRNA,B-locus
target,I-locus
sites,I-locus
in,O
genes,O
of,O
the,O
TGF,B-Gene_protein
-,I-Gene_protein
β,I-Gene_protein
signaling,O
pathway,O
may,O
also,O
be,O
associated,O
with,O
CRC,O
risk,O
,,O
we,O
first,O
systematically,O
scanned,O
the,O
single,B-DNA_Mutation
-,I-DNA_Mutation
nucleotide,I-DNA_Mutation
polymorphisms,I-DNA_Mutation
(,B-DNA_Mutation
SNPs,I-DNA_Mutation
),I-DNA_Mutation
in,O
genes,O
of,O
TGF,B-Gene_protein
-,I-Gene_protein
β,I-Gene_protein
signaling,O
pathway,O
which,O
potentially,O
affect,O
the,O
miRNA,O
/,O
mRNA,O
bindings,O
.,O
 , 
Through,O
a,O
series,O
of,O
filters,O
,,O
we,O
narrowed,O
down,O
these,O
candidates,O
to,O
four,O
SNPs,B-DNA_Mutation
.,I-DNA_Mutation
 , 
Then,O
,,O
we,O
conducted,O
a,O
case,O
-,O
control,O
study,O
with,O
600,O
CRC,O
patients,O
and,O
638,O
controls,O
in,O
Han,O
Chinese,O
population,O
.,O
 , 
We,O
observed,O
that,O
compared,O
with,O
A,O
carriers,O
(,O
AA,O
 ,O
+,O
 ,O
AG,O
),O
,,O
the,O
GG,O
genotype,O
of,O
rs12997,B-dbSNP
:,B-Gene_protein
ACVR1,I-Gene_protein
is,O
associated,O
with,O
a,O
significantly,O
higher,O
risk,O
of,O
CRC,O
(,O
OR,O
 ,O
=,O
 ,O
1.52,O
,,O
95,O
%,O
confidence,O
interval,O
(,O
95,O
%,O
CI,O
),O
 ,O
=,O
 ,O
1.04,O
-,O
2.21,O
,,O
P,O
 ,O
=,O
 ,O
0.031,O
),O
,,O
particularly,O
in,O
nonsmokers,O
with,O
a,O
higher,O
OR,O
of,O
1.63,O
(,O
95,O
%,O
CI,O
 ,O
=,O
 ,O
1.04,O
-,O
2.55,O
,,O
P,O
 ,O
=,O
 ,O
0.032,O
),O
.,O
 , 
Our,O
study,O
suggested,O
that,O
SNPs,B-DNA_Mutation
in,O
miRNA,B-locus
target,I-locus
sites,I-locus
could,O
contribute,O
to,O
the,O
likelihood,O
of,O
CRC,O
susceptibility,O
and,O
emphasized,O
the,O
important,O
role,O
of,O
polymorphisms,B-DNA_Mutation
at,O
miRNA,O
-,O
regulatory,O
elements,O
in,O
carcinogenesis,O
.,O
 , 

,O
 , 
#23236152
Evolutionarily,O
conserved,O
protein,O
ERH,B-Gene_protein
controls,O
CENP,B-Gene_protein
-,I-Gene_protein
E,I-Gene_protein
mRNA,O
splicing,O
and,O
is,O
required,O
for,O
the,O
survival,O
of,O
KRAS,B-Gene_protein
mutant,B-DNA_Mutation
cancer,O
cells,O
.,O
 , 


,O
Cancers,O
with,O
Ras,O
mutations,B-DNA_Mutation
represent,O
a,O
major,O
therapeutic,O
problem,O
.,O
 , 
Recent,O
RNAi,O
screens,O
have,O
uncovered,O
multiple,O
nononcogene,O
addiction,O
pathways,O
that,O
are,O
necessary,O
for,O
the,O
survival,O
of,O
Ras,O
mutant,B-DNA_Mutation
cells,O
.,O
 , 
Here,O
,,O
we,O
identify,O
the,O
evolutionarily,O
conserved,O
gene,O
enhancer,B-Gene_protein
of,I-Gene_protein
rudimentary,I-Gene_protein
homolog,I-Gene_protein
(,B-Gene_protein
ERH,I-Gene_protein
),I-Gene_protein
,,O
in,O
which,O
depletion,O
causes,O
greater,O
toxicity,O
in,O
cancer,O
cells,O
with,O
mutations,B-DNA_Mutation
in,O
the,O
small,O
GTPase,O
KRAS,B-Gene_protein
compared,O
with,O
KRAS,B-Gene_protein
WT,O
cells,O
.,O
 , 
ERH,B-Gene_protein
interacts,O
with,O
the,O
spliceosome,O
protein,O
SNRPD3,B-Gene_protein
and,O
is,O
required,O
for,O
the,O
mRNA,O
splicing,O
of,O
the,O
mitotic,O
motor,O
protein,O
CENP,B-Gene_protein
-,I-Gene_protein
E.,I-Gene_protein
Loss,B-DNA_Mutation
of,O
ERH,B-Gene_protein
leads,O
to,O
loss,B-DNA_Mutation
of,O
CENP,B-Gene_protein
-,I-Gene_protein
E,I-Gene_protein
and,O
consequently,O
,,O
chromosome,O
congression,O
defects,O
.,O
 , 
Gene,O
expression,O
profiling,O
indicates,O
that,O
ERH,B-Gene_protein
is,O
required,O
for,O
the,O
expression,O
of,O
multiple,O
cell,O
cycle,O
genes,O
,,O
and,O
the,O
gene,O
expression,O
signature,O
resulting,O
from,O
ERH,B-Gene_protein
down,O
-,O
regulation,O
inversely,O
correlates,O
with,O
KRAS,B-Gene_protein
signatures,O
.,O
 , 
Clinically,O
,,O
tumor,O
ERH,B-Gene_protein
expression,O
is,O
inversely,O
associated,O
with,O
survival,O
of,O
colorectal,O
cancer,O
patients,O
whose,O
tumors,O
harbor,O
KRAS,B-Gene_protein
mutations,B-DNA_Mutation
.,I-DNA_Mutation
 , 
Together,O
,,O
these,O
findings,O
identify,O
a,O
role,O
of,O
ERH,B-Gene_protein
in,O
mRNA,O
splicing,O
and,O
mitosis,O
,,O
and,O
they,O
provide,O
evidence,O
that,O
KRAS,B-Gene_protein
mutant,B-DNA_Mutation
cancer,O
cells,O
are,O
dependent,O
on,O
ERH,B-Gene_protein
for,O
their,O
survival,O
.,O

,O
 , 
#10844916
Value,O
of,O
predictive,O
genetic,O
testing,O
in,O
management,O
of,O
hereditary,O
non,O
-,O
polyposis,O
colorectal,O
cancer,O
(,O
HNPCC,O
),O



,O
#,O
#,O
OBJECTIVE,O

,O
To,O
investigate,O
the,O
impact,O
of,O
predictive,O
genetic,O
testing,O
on,O
colonoscopic,O
surveillance,O
in,O
an,O
extended,O
family,O
with,O
hereditary,O
non,O
-,O
polyposis,O
colorectal,O
cancer,O
(,O
HNPCC,O
),O
.,O
 , 


,O
#,O
#,O
SETTING,O

,O
Familial,O
Bowel,O
Cancer,O
Service,O
,,O
The,O
Royal,O
Melbourne,O
Hospital,O
,,O
Victoria,O
.,O
 , 


,O
#,O
#,O
SUBJECTS,O

,O
96,O
people,O
registered,O
with,O
the,O
Service,O
who,O
were,O
apparently,O
unaffected,O
members,O
of,O
an,O
extended,O
family,O
that,O
met,O
the,O
classic,O
Amsterdam,O
criteria,O
for,O
HNPCC,O
and,O
carried,O
an,O
MLH1,B-Gene_protein
gene,O
mutation,B-DNA_Mutation
(,B-DNA_Mutation
IVS9,I-DNA_Mutation
+,I-DNA_Mutation
3insT,I-DNA_Mutation
),I-DNA_Mutation
.,O
 , 


,O
#,O
#,O
INTERVENTION,O

,O
Predictive,O
genetic,O
testing,O
was,O
offered,O
in,O
a,O
cascade,O
manner,O
to,O
at,O
-,O
risk,O
family,O
members,O
;,O
mutation,B-DNA_Mutation
-,I-DNA_Mutation
positive,O
individuals,O
were,O
advised,O
to,O
have,O
annual,O
colonoscopic,O
surveillance,O
,,O
while,O
mutation,B-DNA_Mutation
-,I-DNA_Mutation
negative,O
individuals,O
were,O
withdrawn,O
from,O
surveillance,O
.,O
 , 


,O
#,O
#,O
MAIN,O
OUTCOME,O
MEASURES,O

,O
Previous,O
compliance,O
with,O
recommended,O
colonoscopic,O
surveillance,O
;,O
uptake,O
and,O
results,O
of,O
genetic,O
testing,O
;,O
expected,O
effect,O
of,O
genetic,O
test,O
results,O
on,O
number,O
of,O
colonoscopies,O
over,O
five,O
years,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
22,O
of,O
the,O
96,O
family,O
members,O
(,O
23,O
%,O
),O
were,O
not,O
complying,O
with,O
recommended,O
surveillance,O
.,O
 , 
Of,O
48,O
individuals,O
offered,O
predictive,O
genetic,O
testing,O
,,O
41,O
(,O
85,O
%,O
),O
responded,O
and,O
39,O
(,O
81,O
%,O
),O
underwent,O
testing,O
.,O
 , 
Seven,O
of,O
the,O
39,O
(,O
18,O
%,O
),O
were,O
positive,O
for,O
the,O
family,O
-,O
specific,O
mutation,B-DNA_Mutation
,,I-DNA_Mutation
and,O
32,O
(,O
82,O
%,O
),O
were,O
negative,O
.,O
 , 
The,O
39,O
tested,O
individuals,O
and,O
37,O
of,O
their,O
descendants,O
who,O
were,O
registered,O
with,O
the,O
screening,O
program,O
had,O
undergone,O
70,O
colonoscopies,O
in,O
the,O
five,O
years,O
before,O
genetic,O
testing,O
.,O
 , 
In,O
the,O
five,O
years,O
after,O
testing,O
,,O
only,O
37,O
surveillance,O
colonoscopies,O
were,O
planned,O
(,O
annual,O
or,O
two,O
-,O
yearly,O
colonoscopies,O
for,O
the,O
six,O
mutation,B-DNA_Mutation
-,I-DNA_Mutation
positive,O
individuals,O
and,O
five,O
-,O
yearly,O
colonoscopies,O
for,O
four,O
mutation,B-DNA_Mutation
-,I-DNA_Mutation
negative,O
individuals,O
with,O
previously,O
identified,O
adenoma,O
),O
,,O
an,O
almost,O
50,O
%,O
reduction,O
in,O
colonoscopies,O
.,O
 , 


,O
#,O
#,O
CONCLUSION,O

,O
Predictive,O
genetic,O
testing,O
in,O
HNPCC,O
families,O
allows,O
many,O
individuals,O
to,O
be,O
withdrawn,O
from,O
regular,O
colonoscopic,O
surveillance,O
.,O
 , 
It,O
may,O
therefore,O
reduce,O
costs,O
,,O
as,O
well,O
as,O
have,O
emotional,O
benefits,O
for,O
many,O
individuals,O
.,O

,O
 , 
#23196986
Genomic,O
analysis,O
and,O
selected,O
molecular,O
pathways,O
in,O
rare,O
cancers,O
.,O
 , 


,O
It,O
is,O
widely,O
accepted,O
that,O
many,O
cancers,O
arise,O
as,O
a,O
result,O
of,O
an,O
acquired,O
genomic,B-DNA_Mutation
instability,I-DNA_Mutation
and,O
the,O
subsequent,O
evolution,O
of,O
tumor,O
cells,O
with,O
variable,O
patterns,O
of,O
selected,O
and,O
background,O
aberrations,O
.,O
 , 
The,O
presence,O
and,O
behaviors,O
of,O
distinct,O
neoplastic,O
cell,O
populations,O
within,O
a,O
patient,O
's,O
tumor,O
may,O
underlie,O
multiple,O
clinical,O
phenotypes,O
in,O
cancers,O
.,O
 , 
A,O
goal,O
of,O
many,O
current,O
cancer,O
genome,O
studies,O
is,O
the,O
identification,O
of,O
recurring,O
selected,O
driver,O
events,O
that,O
can,O
be,O
advanced,O
for,O
the,O
development,O
of,O
personalized,O
therapies,O
.,O
 , 
Unfortunately,O
,,O
in,O
the,O
majority,O
of,O
rare,O
tumors,O
,,O
this,O
type,O
of,O
analysis,O
can,O
be,O
particularly,O
challenging,O
.,O
 , 
Large,O
series,O
of,O
specimens,O
for,O
analysis,O
are,O
simply,O
not,O
available,O
,,O
allowing,O
recurring,O
patterns,O
to,O
remain,O
hidden,O
.,O
 , 
In,O
this,O
paper,O
,,O
we,O
highlight,O
the,O
use,O
of,O
DNA,O
content,O
-,O
based,O
flow,O
sorting,O
to,O
identify,O
and,O
isolate,O
DNA,O
-,O
diploid,O
and,O
DNA,O
-,B-DNA_Mutation
aneuploid,I-DNA_Mutation
populations,O
from,O
tumor,O
biopsies,O
as,O
a,O
strategy,O
to,O
comprehensively,O
study,O
the,O
genomic,O
composition,O
and,O
behaviors,O
of,O
individual,O
cancers,O
in,O
a,O
series,O
of,O
rare,O
solid,O
tumors,O
:,O
intrahepatic,O
cholangiocarcinoma,O
,,O
anal,O
carcinoma,O
,,O
adrenal,O
leiomyosarcoma,O
,,O
and,O
pancreatic,O
neuroendocrine,O
tumors,O
.,O
 , 
We,O
propose,O
that,O
the,O
identification,O
of,O
highly,O
selected,O
genomic,O
events,O
in,O
distinct,O
tumor,O
populations,O
within,O
each,O
tumor,O
can,O
identify,O
candidate,O
driver,O
events,O
that,O
can,O
facilitate,O
the,O
development,O
of,O
novel,O
,,O
personalized,O
treatment,O
strategies,O
for,O
patients,O
with,O
cancer,O
.,O
 , 

,O
 , 
#22348132
MiRNA,O
genes,O
constitute,O
new,O
targets,O
for,O
microsatellite,B-RNA_Mutation
instability,I-RNA_Mutation
in,O
colorectal,O
cancer,O
.,O
 , 


,O
Mismatch,O
repair,O
-,O
deficient,O
colorectal,O
cancers,O
(,O
CRC,O
),O
display,O
widespread,O
instability,B-RNA_Mutation
at,O
DNA,O
microsatellite,B-locus
sequences,O
(,B-RNA_Mutation
MSI,I-RNA_Mutation
),I-RNA_Mutation
.,O
 , 
Although,O
MSI,B-RNA_Mutation
has,O
been,O
reported,O
to,O
commonly,O
occur,O
at,O
coding,O
repeats,O
,,O
leading,O
to,O
alterations,O
in,O
the,O
function,O
of,O
a,O
number,O
of,O
genes,O
encoding,O
cancer,O
-,O
related,O
proteins,O
,,O
nothing,O
is,O
known,O
about,O
the,O
putative,O
impact,O
of,O
this,O
process,O
on,O
non,O
-,O
coding,O
microRNAs,O
.,O
 , 
In,O
miRbase,O
V15,O
,,O
we,O
identified,O
very,O
few,O
human,O
microRNA,O
genes,O
with,O
mono-,O
or,O
di,O
-,O
nucleotide,O
repeats,O
(,O
n,O
=,O
27,O
),O
.,O
 , 
A,O
mutational,O
analysis,O
of,O
these,O
sequences,O
in,O
a,O
large,O
series,O
of,O
MSI,B-RNA_Mutation
CRC,O
cell,O
lines,O
and,O
primary,O
tumors,O
underscored,O
instability,B-RNA_Mutation
in,O
15,O
of,O
the,O
24,O
microRNA,O
genes,O
successfully,O
studied,O
at,O
variable,O
frequencies,O
ranging,O
from,O
2.5,O
%,O
to,O
100,O
%,O
.,O
 , 
Following,O
a,O
maximum,O
likelihood,O
statistical,O
method,O
,,O
microRNA,O
genes,O
were,O
separated,O
into,O
two,O
groups,O
that,O
differed,O
significantly,O
in,O
their,O
mutation,B-RNA_Mutation
frequencies,O
and,O
in,O
their,O
tendency,O
to,O
represent,O
mutations,B-RNA_Mutation
that,O
may,O
or,O
may,O
not,O
be,O
under,O
selective,O
pressures,O
during,O
MSI,B-RNA_Mutation
tumoral,O
progression,O
.,O
 , 
The,O
first,O
group,O
included,O
21,O
genes,O
that,O
displayed,O
no,O
or,O
few,O
mutations,B-RNA_Mutation
in,O
CRC,O
.,O
 , 
The,O
second,O
group,O
contained,O
three,O
genes,O
,,O
i.e.,O
,,O
hsa,B-RNA
-,I-RNA
mir-1273c,I-RNA
,,I-RNA
hsa,B-RNA
-,I-RNA
mir-1303,I-RNA
and,O
hsa,B-RNA
-,I-RNA
mir-567,I-RNA
,,I-RNA
with,O
frequent,O
(,O
≥,O
80,O
%,O
),O
and,O
sometimes,O
bi,O
-,O
allelic,O
mutations,B-RNA_Mutation
in,O
MSI,B-RNA_Mutation
tumors,O
.,O
 , 
For,O
the,O
only,O
one,O
expressed,O
in,O
colonic,O
tissues,O
,,O
hsa,B-RNA
-,I-RNA
mir-1303,I-RNA
,,I-RNA
no,O
direct,O
link,O
was,O
found,O
between,O
the,O
presence,O
or,O
not,O
of,O
mono-,O
or,O
bi,O
-,O
allelic,O
alterations,B-RNA_Mutation
and,O
the,O
levels,O
of,O
mature,O
miR,O
expression,O
in,O
MSI,B-RNA_Mutation
cell,O
lines,O
,,O
as,O
determined,O
by,O
sequencing,O
and,O
quantitative,O
PCR,O
respectively,O
.,O
 , 
Overall,O
,,O
our,O
results,O
provide,O
evidence,O
that,O
DNA,O
repeats,O
contained,O
in,O
human,O
miRNA,O
genes,O
are,O
relatively,O
rare,O
and,O
preserved,O
from,O
mutations,O
due,O
to,O
MSI,B-RNA_Mutation
in,O
MMR,O
-,O
deficient,O
cancer,O
cells,O
.,O
 , 
Functional,O
studies,O
are,O
now,O
required,O
to,O
conclude,O
whether,O
mutated,O
miRNAs,O
,,O
and,O
especially,O
the,O
miR-1303,B-RNA
,,I-RNA
might,O
have,O
a,O
role,O
in,O
MSI,B-RNA_Mutation
tumorigenesis,O
.,O
 , 

,O
 , 
#10690536
Mutational,O
analysis,O
of,O
the,O
transforming,B-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
beta,I-Gene_protein
receptor,I-Gene_protein
type,I-Gene_protein
II,I-Gene_protein
gene,O
in,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
and,O
early,O
-,O
onset,O
colorectal,O
cancer,O
patients,O
.,O
 , 


,O
Somatic,O
mutations,B-DNA_Mutation
in,O
the,O
transforming,B-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
beta,I-Gene_protein
receptor,I-Gene_protein
type,I-Gene_protein
II,I-Gene_protein
(,B-Gene_protein
TGF,I-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
RII,I-Gene_protein
),I-Gene_protein
gene,O
have,O
been,O
observed,O
in,O
various,O
human,O
cancers,O
showing,O
microsatellite,B-DNA_Mutation
instability,I-DNA_Mutation
.,I-DNA_Mutation
 , 
Most,O
of,O
the,O
mutations,B-DNA_Mutation
observed,O
were,O
additions,B-DNA_Mutation
or,O
deletions,B-DNA_Mutation
of,O
the,O
mononucleotide,O
repeat,O
sequence,O
present,O
in,O
TGF,B-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
RII,I-Gene_protein
coding,O
region,O
,,O
suggesting,O
that,O
the,O
TGF,B-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
RII,I-Gene_protein
may,O
be,O
a,O
target,O
gene,O
of,O
genomic,B-DNA_Mutation
instability,I-DNA_Mutation
in,O
tumorigenesis,O
.,O
 , 
Recently,O
,,O
we,O
reported,O
germ,O
-,O
line,O
frameshift,B-DNA_Mutation
mutations,I-DNA_Mutation
in,O
the,O
mononucleotide,O
repeat,O
sequence,O
of,O
the,O
hMSH6,B-Gene_protein
gene,O
,,O
which,O
is,O
believed,O
to,O
be,O
one,O
of,O
the,O
target,O
genes,O
of,O
genomic,B-DNA_Mutation
instability,I-DNA_Mutation
in,O
tumorigenesis,O
,,O
suggesting,O
the,O
possibility,O
of,O
germ,O
-,O
line,O
mutation,B-DNA_Mutation
in,O
mononucleotide,O
repeat,O
sequences,O
.,O
 , 
Moreover,O
,,O
one,O
case,O
of,O
germ,O
-,O
line,O
mutation,B-DNA_Mutation
in,O
the,O
TGF,B-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
RII,I-Gene_protein
gene,O
was,O
identified,O
in,O
a,O
hereditary,O
nonpolyposis,O
colorectal,O
cancer,O
(,O
HNPCC,O
),O
kindred,O
,,O
indicating,O
the,O
involvement,O
of,O
TGF,B-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
RII,I-Gene_protein
inactivation,O
in,O
tumorigenesis,O
of,O
HNPCC,O
.,O
 , 
However,O
,,O
germ,O
-,O
line,O
mutation,B-DNA_Mutation
analysis,O
of,O
all,O
of,O
the,O
coding,O
sequences,O
and,O
the,O
mononucleotide,O
repeat,O
sequence,O
of,O
the,O
TGF,B-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
RII,I-Gene_protein
in,O
HNPCC,O
patients,O
has,O
not,O
yet,O
been,O
fully,O
elucidated,O
.,O
 , 
Therefore,O
,,O
to,O
further,O
investigate,O
the,O
presence,O
of,O
germ,O
-,O
line,O
mutations,B-DNA_Mutation
,,I-DNA_Mutation
we,O
screened,O
all,O
of,O
the,O
coding,O
region,O
sequences,O
and,O
mononucleotide,O
repeat,O
sequence,O
of,O
TGF,B-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
RII,I-Gene_protein
from,O
35,O
HNPCC,O
,,O
44,O
suspected,O
HNPCC,O
,,O
and,O
45,O
sporadic,O
early,O
-,O
onset,O
colorectal,O
cancer,O
patients,O
.,O
 , 
However,O
,,O
no,O
pathogenic,B-DNA_Mutation
mutations,I-DNA_Mutation
other,O
than,O
silent,B-DNA_Mutation
mutations,I-DNA_Mutation
,,I-DNA_Mutation
introgenic,B-locus
mutation,B-DNA_Mutation
,,I-DNA_Mutation
and,O
polymorphisms,B-DNA_Mutation
were,O
identified,O
.,O
 , 
Two,O
silent,B-DNA_Mutation
mutations,I-DNA_Mutation
at,O
codons,B-locus
309,I-locus
(,B-DNA_Mutation
ACG,I-DNA_Mutation
to,I-DNA_Mutation
ACA,I-DNA_Mutation
),I-DNA_Mutation
and,O
340,B-locus
(,B-DNA_Mutation
CAT,I-DNA_Mutation
to,I-DNA_Mutation
CAC,I-DNA_Mutation
),I-DNA_Mutation
in,O
the,O
kinase,B-locus
domain,I-locus
located,O
in,O
exon,B-locus
4,I-locus
were,O
detected,O
.,O
 , 
A,O
1,O
-,O
bp,O
cytidine,O
deletion,B-DNA_Mutation
was,O
observed,O
6,B-locus
bases,I-locus
from,I-locus
the,I-locus
3,I-locus
',I-locus
end,I-locus
of,I-locus
intron,I-locus
.,I-locus
 , 
Two,O
polymorphisms,B-DNA_Mutation
were,O
identified,O
at,O
codon,B-locus
389,I-locus
(,B-DNA_Mutation
AAC,I-DNA_Mutation
to,I-DNA_Mutation
AAT,I-DNA_Mutation
),I-DNA_Mutation
and,O
at,O
the,O
fourth,B-locus
-,I-locus
to,I-locus
-,I-locus
last,I-locus
base,I-locus
in,I-locus
intron,I-locus
3,I-locus
.,I-locus
 , 
The,O
polymorphism,B-DNA_Mutation
at,O
codon,B-locus
389,I-locus
was,O
more,O
frequent,O
in,O
HNPCC,O
(,O
20,O
%,O
;,O
7,O
of,O
35,O
),O
and,O
suspected,O
HNPCC,O
patients,O
(,O
18,O
%,O
;,O
8,O
of,O
44,O
),O
than,O
in,O
nonmalignant,O
control,O
group,O
(,O
10,O
%,O
;,O
5,O
of,O
50,O
),O
.,O
 , 
Moreover,O
,,O
the,O
frequency,O
was,O
significantly,O
higher,O
in,O
early,O
-,O
onset,O
colorectal,O
cancer,O
patients,O
(,O
31,O
%,O
;,O
14,O
of,O
45,O
),O
.,O
 , 
This,O
is,O
the,O
first,O
report,O
of,O
a,O
different,O
frequency,O
of,O
polymorphism,B-DNA_Mutation
in,O
HNPCC,O
,,O
suspected,O
HNPCC,O
,,O
early,O
-,O
onset,O
colorectal,O
cancer,O
patients,O
,,O
and,O
healthy,O
normal,O
individuals,O
.,O
 , 
This,O
result,O
suggests,O
that,O
:,O
(,O
a,O
),O
germ,O
-,O
line,O
mutation,B-DNA_Mutation
of,O
the,O
TGF,B-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
RII,I-Gene_protein
gene,O
may,O
be,O
a,O
rare,O
event,O
during,O
tumorigenesis,O
in,O
HNPCC,O
and,O
sporadic,O
early,O
-,O
onset,O
colorectal,O
cancer,O
;,O
(,O
b,O
),O
the,O
mononucleotide,O
repeat,O
sequence,O
of,O
the,O
TGF,B-Gene_protein
-,I-Gene_protein
beta,I-Gene_protein
RII,I-Gene_protein
gene,O
is,O
an,O
apparent,O
target,O
of,O
genomic,B-DNA_Mutation
instability,I-DNA_Mutation
but,O
not,O
of,O
germ,O
-,O
line,O
mutation,B-DNA_Mutation
;,I-DNA_Mutation
and,O
(,O
c,O
),O
the,O
polymorphism,B-DNA_Mutation
of,O
codon,B-locus
389,I-locus
(,B-DNA_Mutation
AAC,I-DNA_Mutation
to,I-DNA_Mutation
AAT,I-DNA_Mutation
),I-DNA_Mutation
is,O
frequent,O
,,O
especially,O
in,O
early,O
-,O
onset,O
colorectal,O
cancer,O
patients,O
,,O
in,O
which,O
it,O
is,O
more,O
frequent,O
than,O
in,O
control,O
group,O
.,O
 , 

,O
 , 
#22565629
A,O
review,O
of,O
spatial,O
computational,O
models,O
for,O
multi,O
-,O
cellular,O
systems,O
,,O
with,O
regard,O
to,O
intestinal,O
crypts,O
and,O
colorectal,O
cancer,O
development,O
.,O
 , 


,O
Colon,O
rectal,O
cancers,O
(,O
CRC,O
),O
are,O
the,O
result,O
of,O
sequences,O
of,O
mutations,B-Mutation
which,O
lead,O
the,O
intestinal,O
tissue,O
to,O
develop,O
in,O
a,O
carcinoma,O
following,O
a,O
",O
progression,O
",O
of,O
observable,O
phenotypes,O
.,O
 , 
The,O
actual,O
modeling,O
and,O
simulation,O
of,O
the,O
key,O
biological,O
structures,O
involved,O
in,O
this,O
process,O
is,O
of,O
interest,O
to,O
biologists,O
and,O
physicians,O
and,O
,,O
at,O
the,O
same,O
time,O
,,O
it,O
poses,O
significant,O
challenges,O
from,O
the,O
mathematics,O
and,O
computer,O
science,O
viewpoints,O
.,O
 , 
In,O
this,O
report,O
we,O
give,O
an,O
overview,O
of,O
some,O
mathematical,O
models,O
for,O
cell,O
sorting,O
(,O
a,O
basic,O
phenomenon,O
that,O
underlies,O
several,O
dynamical,O
processes,O
in,O
an,O
organism,O
),O
,,O
intestinal,O
crypt,O
dynamics,O
and,O
related,O
problems,O
and,O
open,O
questions,O
.,O
 , 
In,O
particular,O
,,O
major,O
attention,O
is,O
devoted,O
to,O
the,O
survey,O
of,O
so,O
-,O
called,O
in,O
-,O
lattice,O
(,O
or,O
grid,O
),O
models,O
and,O
off,O
-,O
lattice,O
(,O
off,O
-,O
grid,O
),O
models,O
.,O
 , 
The,O
current,O
work,O
is,O
the,O
groundwork,O
for,O
future,O
research,O
on,O
semi,O
-,O
automated,O
hypotheses,O
formation,O
and,O
testing,O
about,O
the,O
behavior,O
of,O
the,O
various,O
actors,O
taking,O
part,O
in,O
the,O
adenoma,O
-,O
carcinoma,O
progression,O
,,O
from,O
regulatory,O
processes,O
to,O
cell,O
-,O
cell,O
signaling,O
pathways,O
.,O
 , 

,O
 , 
#21734388
Colon,O
cancer,O
:,O
a,O
civilization,O
disorder,O
.,O
 , 


,O
Colorectal,O
cancer,O
arises,O
in,O
individuals,O
with,O
acquired,O
or,O
inherited,O
genetic,O
predisposition,O
who,O
are,O
exposed,O
to,O
a,O
range,O
of,O
risk,O
factors,O
.,O
 , 
Many,O
of,O
these,O
risk,O
factors,O
are,O
associated,O
with,O
affluent,O
Western,O
societies,O
.,O
 , 
More,O
than,O
95,O
%,O
of,O
colorectal,O
cancers,O
are,O
sporadic,O
,,O
arising,O
in,O
individuals,O
without,O
a,O
significant,O
hereditary,O
risk,O
.,O
 , 
Geographic,O
variation,O
in,O
the,O
incidence,O
of,O
colorectal,O
cancer,O
is,O
considerable,O
with,O
a,O
higher,O
incidence,O
observed,O
in,O
the,O
West,O
.,O
 , 
Environmental,O
factors,O
contribute,O
substantially,O
to,O
this,O
variation,O
.,O
 , 
A,O
number,O
of,O
these,O
risk,O
factors,O
are,O
associated,O
with,O
a,O
Western,O
lifestyle,O
and,O
could,O
be,O
considered,O
a,O
product,O
of,O
',O
civilization,O
',O
.,O
 , 
Recently,O
,,O
smoking,O
has,O
been,O
recognized,O
as,O
a,O
risk,O
factor,O
.,O
 , 
Energy,O
consumption,O
also,O
influences,O
colorectal,O
cancer,O
risk,O
,,O
with,O
obesity,O
increasing,O
risk,O
and,O
exercise,O
reducing,O
risk,O
.,O
 , 
However,O
,,O
the,O
strongest,O
contribution,O
to,O
environmental,O
risk,O
for,O
colorectal,O
cancer,O
is,O
dietary,O
.,O
 , 
Consumption,O
of,O
fat,O
,,O
alcohol,O
and,O
red,O
meat,O
is,O
associated,O
with,O
an,O
increased,O
risk,O
.,O
 , 
Fresh,O
fruit,O
and,O
vegetables,O
and,O
dietary,O
fibre,O
may,O
be,O
protective,O
.,O
 , 
Much,O
has,O
been,O
learnt,O
recently,O
about,O
the,O
molecular,O
pathogenesis,O
of,O
colorectal,O
cancer,O
.,O
 , 
Colorectal,O
cancer,O
always,O
arises,O
in,O
the,O
context,O
of,O
genomic,B-DNA_Mutation
instability,I-DNA_Mutation
.,I-DNA_Mutation
 , 
There,O
is,O
inactivation,O
of,O
the,O
tumour,O
suppressor,O
genes,O
adenomatous,O
polyposis,O
coli,O
,,O
p53,B-Gene_protein
,,I-Gene_protein
transforming,B-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
-,I-Gene_protein
β,I-Gene_protein
,,I-Gene_protein
activation,O
of,O
oncogene,O
pathways,O
including,O
K,B-Gene_protein
-,I-Gene_protein
ras,I-Gene_protein
,,I-Gene_protein
and,O
activation,O
of,O
the,O
cyclooxygenase-2,B-Gene_protein
,,I-Gene_protein
epidermal,B-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
receptor,I-Gene_protein
and,O
vascular,B-Gene_protein
endothelial,I-Gene_protein
growth,I-Gene_protein
factor,I-Gene_protein
pathways,O
.,O
 , 
The,O
mechanisms,O
by,O
which,O
some,O
environmental,O
factors,O
modify,O
the,O
mutation,B-DNA_Mutation
risk,O
in,O
these,O
pathways,O
have,O
been,O
described,O
.,O
 , 

,O
 , 
#21948089
Complex,O
patterns,O
of,O
altered,O
MicroRNA,O
expression,O
during,O
the,O
adenoma,O
-,O
adenocarcinoma,O
sequence,O
for,O
microsatellite,O
-,O
stable,O
colorectal,O
cancer,O
.,O
 , 



,O
#,O
#,O
PURPOSE,O

,O
MicroRNAs,O
are,O
short,O
noncoding,O
RNAs,O
that,O
regulate,O
gene,O
expression,O
and,O
are,O
over-,O
or,O
underexpressed,O
in,O
most,O
tumors,O
,,O
including,O
colorectal,O
adenocarcinoma,O
.,O
 , 
MicroRNAs,O
are,O
potential,O
biomarkers,O
and,O
therapeutic,O
targets,O
and,O
agents,O
,,O
but,O
limited,O
information,O
on,O
microRNAome,O
alterations,O
during,O
progression,O
in,O
the,O
well,O
-,O
known,O
adenoma,O
-,O
adenocarcinoma,O
sequence,O
is,O
available,O
to,O
guide,O
their,O
usage,O
.,O
 , 


,O
#,O
#,O
EXPERIMENTAL,O
DESIGN,O

,O
 , 
We,O
profiled,O
866,O
human,O
microRNAs,O
by,O
microarray,O
analysis,O
in,O
69,O
matched,O
specimens,O
of,O
microsatellite,O
-,O
stable,O
adenocarcinomas,O
,,O
adjoining,O
precursor,O
adenomas,O
including,O
areas,O
of,O
high-,O
and,O
low,O
-,O
grade,O
dysplasia,O
,,O
and,O
nonneoplastic,O
mucosa,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
We,O
found,O
230,O
microRNAs,O
that,O
were,O
significantly,O
differentially,O
expressed,O
during,O
progression,O
,,O
including,O
19,O
not,O
reported,O
previously,O
.,O
 , 
Altered,O
microRNAs,O
clustered,O
into,O
two,O
major,O
patterns,O
of,O
early,O
(,O
type,O
I,O
),O
and,O
late,O
(,O
type,O
II,O
),O
differential,O
expression,O
.,O
 , 
The,O
largest,O
number,O
(,O
n,O
=,O
108,O
),O
was,O
altered,O
at,O
the,O
earliest,O
step,O
from,O
mucosa,O
to,O
low,O
-,O
grade,O
dysplasia,O
(,O
subtype,O
IA,O
),O
prior,O
to,O
major,O
nuclear,O
localization,O
of,O
β,B-Gene_protein
-,I-Gene_protein
catenin,I-Gene_protein
,,I-Gene_protein
including,O
36,O
microRNAs,O
that,O
had,O
persistent,O
differential,O
expression,O
throughout,O
the,O
entire,O
sequence,O
to,O
adenocarcinoma,O
.,O
 , 
Twenty,O
microRNAs,O
were,O
intermittently,O
altered,O
(,O
subtype,O
IB,O
),O
,,O
and,O
six,O
were,O
transiently,O
altered,O
(,O
subtype,O
IC,O
),O
.,O
 , 
In,O
contrast,O
,,O
33,O
microRNAs,O
were,O
altered,O
late,O
in,O
high,O
-,O
grade,O
dysplasia,O
and,O
adenocarcinoma,O
(,O
subtype,O
IIA,O
),O
,,O
and,O
63,O
in,O
adenocarcinoma,O
only,O
(,O
subtype,O
IIB,O
),O
.,O
 , 
Predicted,O
targets,O
in,O
12,O
molecular,O
pathways,O
were,O
identified,O
for,O
highly,O
altered,O
microRNAs,O
,,O
including,O
the,O
Wnt,O
signaling,O
pathway,O
leading,O
to,O
low,O
-,O
grade,O
dysplasia,O
.,O
 , 
β,B-Gene_protein
-,I-Gene_protein
catenin,I-Gene_protein
expression,O
correlated,O
with,O
downregulated,O
microRNAs,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
Our,O
findings,O
suggest,O
that,O
numerous,O
microRNAs,O
play,O
roles,O
in,O
the,O
sequence,O
of,O
molecular,O
events,O
,,O
especially,O
early,O
events,O
,,O
resulting,O
in,O
colorectal,O
adenocarcinoma,O
.,O
 , 
The,O
temporal,O
patterns,O
and,O
complexity,O
of,O
microRNAome,O
alterations,O
during,O
progression,O
will,O
influence,O
the,O
efficacy,O
of,O
microRNAs,O
for,O
clinical,O
purposes,O
.,O

,O
 , 
#15929776
Noninvasive,O
testing,O
for,O
colorectal,O
cancer,O
:,O
a,O
review,O
.,O
 , 



,O
#,O
#,O
OBJECTIVES,O

,O
Colorectal,O
cancer,O
(,O
CRC,O
),O
is,O
the,O
second,O
leading,O
cause,O
of,O
cancer,O
-,O
related,O
death,O
in,O
the,O
United,O
States,O
.,O
 , 
Endoscopic,O
screening,O
is,O
now,O
in,O
favor,O
and,O
its,O
use,O
is,O
increasing,O
,,O
but,O
overall,O
participation,O
rates,O
are,O
poor,O
.,O
 , 
A,O
substantial,O
percentage,O
of,O
the,O
population,O
will,O
likely,O
continue,O
to,O
resist,O
endoscopic,O
screening,O
.,O
 , 
As,O
such,O
,,O
a,O
noninvasive,O
biomarker,O
for,O
the,O
early,O
detection,O
of,O
CRC,O
remains,O
a,O
priority,O
.,O
 , 
Herein,O
,,O
we,O
(,O
i,O
),O
review,O
the,O
currently,O
available,O
noninvasive,O
screening,O
markers,O
for,O
the,O
early,O
detection,O
of,O
CRC,O
,,O
(,O
ii,O
),O
discuss,O
newer,O
markers,O
that,O
have,O
undergone,O
preliminary,O
testing,O
,,O
and,O
(,O
iii,O
),O
introduce,O
and,O
explain,O
potentially,O
promising,O
markers,O
of,O
the,O
future,O
.,O
 , 


,O
#,O
#,O
METHODS,O

,O
 , 
The,O
published,O
literature,O
on,O
markers,O
for,O
early,O
detection,O
of,O
CRC,O
was,O
identified,O
using,O
a,O
MEDLINE,O
/,O
PubMed,O
search,O
with,O
secondary,O
review,O
of,O
cited,O
publications,O
.,O
 , 


,O
#,O
#,O
RESULTS,O

,O
Noninvasive,O
testing,O
for,O
CRC,O
is,O
most,O
advanced,O
in,O
testing,O
for,O
stool,O
fecal,O
occult,O
blood,O
,,O
globin,O
,,O
or,O
DNA,O
mutations,B-DNA_Mutation
.,I-DNA_Mutation
 , 
Study,O
of,O
abnormal,O
mucins,O
has,O
also,O
been,O
explored,O
.,O
 , 
Research,O
for,O
serum,O
-,O
based,O
markers,O
is,O
just,O
beginning,O
and,O
includes,O
serum,O
proteomics,O
,,O
nuclear,O
matrix,O
proteins,O
,,O
and,O
serum,O
DNA,O
testing,O
.,O
 , 


,O
#,O
#,O
CONCLUSIONS,O

,O
Serial,O
guaiac,O
-,O
based,O
fecal,O
occult,O
blood,O
testing,O
(,O
FOBT,O
),O
is,O
simple,O
,,O
inexpensive,O
,,O
and,O
proven,O
effective,O
at,O
reducing,O
mortality,O
from,O
CRC,O
.,O
 , 
Immunochemical,O
fecal,O
occult,O
blood,O
tests,O
facilitate,O
compliance,O
and,O
offer,O
improved,O
specificity,O
,,O
but,O
at,O
increased,O
cost,O
in,O
comparison,O
to,O
FOBT,O
.,O
 , 
Fecal,O
DNA,O
testing,O
may,O
provide,O
enhanced,O
sensitivity,O
for,O
detection,O
of,O
CRC,O
in,O
comparison,O
with,O
FOBT,O
,,O
but,O
its,O
high,O
cost,O
limits,O
its,O
use,O
for,O
generalized,O
screening,O
.,O
 , 
Rectal,O
mucin,O
testing,O
requires,O
additional,O
evaluation,O
to,O
determine,O
its,O
sensitivity,O
and,O
specificity,O
in,O
comparison,O
with,O
guaiac,O
-,O
based,O
FOBT,O
.,O
 , 
Serum,O
tests,O
,,O
such,O
as,O
proteomics,O
,,O
nuclear,O
matrix,O
proteins,O
,,O
and,O
serum,O
DNA,O
,,O
are,O
still,O
in,O
their,O
infancy,O
,,O
but,O
remain,O
a,O
hope,O
for,O
the,O
future,O
.,O
 , 

,O
 , 
